ID   HS90A_HUMAN             Reviewed;         732 AA.
AC   P07900; A8K500; B3KPJ9; Q2PP14; Q5CAQ6; Q5CAQ7; Q9BVQ5;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 5.
DT   28-JAN-2026, entry version 283.
DE   RecName: Full=Heat shock protein HSP 90-alpha {ECO:0000305};
DE            EC=3.6.4.10 {ECO:0000269|PubMed:12526792};
DE   AltName: Full=Heat shock 86 kDa;
DE            Short=HSP 86;
DE            Short=HSP86;
DE   AltName: Full=Heat shock protein family C member 1;
DE   AltName: Full=Lipopolysaccharide-associated protein 2;
DE            Short=LAP-2;
DE            Short=LPS-associated protein 2;
DE   AltName: Full=Renal carcinoma antigen NY-REN-38;
GN   Name=HSP90AA1 {ECO:0000312|HGNC:HGNC:5253};
GN   Synonyms=HSP90A, HSPC1, HSPCA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Peripheral blood lymphocyte;
RX   PubMed=2780322; DOI=10.1093/nar/17.17.7108;
RA   Soeda E., Yokoyama K., Yamazaki M., Akaogi K., Miwa T., Imai T.;
RT   "Nucleotide sequence of a full-length cDNA for 90 kDa heat-shock protein
RT   from human peripheral blood lymphocytes.";
RL   Nucleic Acids Res. 17:7108-7108(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1368637; DOI=10.1271/bbb1961.54.3163;
RA   Yamazaki M., Tashiro H., Yokoyama K., Soeda E.;
RT   "Molecular cloning of cDNA encoding a human heat-shock protein whose
RT   expression is induced by adenovirus type 12 E1A in HeLa cells.";
RL   Agric. Biol. Chem. 54:3163-3170(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Placenta;
RX   PubMed=2527334; DOI=10.1128/mcb.9.6.2615-2626.1989;
RA   Hickey E., Brandon S.E., Smale G., Lloyd D., Weber L.A.;
RT   "Sequence and regulation of a gene encoding a human 89-kilodalton heat
RT   shock protein.";
RL   Mol. Cell. Biol. 9:2615-2626(1989).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND NOMENCLATURE.
RX   PubMed=16269234; DOI=10.1016/j.ygeno.2005.08.012;
RA   Chen B., Piel W.H., Gui L., Bruford E., Monteiro A.;
RT   "The HSP90 family of genes in the human genome: insights into their
RT   divergence and evolution.";
RL   Genomics 86:627-637(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (DEC-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Placenta, and Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S., Sun H.,
RA   Du H., Pepin K., Artiguenave F., Robert C., Cruaud C., Bruels T.,
RA   Jaillon O., Friedlander L., Samson G., Brottier P., Cure S., Segurens B.,
RA   Aniere F., Samain S., Crespeau H., Abbasi N., Aiach N., Boscus D.,
RA   Dickhoff R., Dors M., Dubois I., Friedman C., Gouyvenoux M., James R.,
RA   Madan A., Mairey-Estrada B., Mangenot S., Martins N., Menard M., Oztas S.,
RA   Ratcliffe A., Shaffer T., Trask B., Vacherie B., Bellemere C., Belser C.,
RA   Besnard-Gonnet M., Bartol-Mavel D., Boutard M., Briez-Silla S.,
RA   Combette S., Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C.,
RA   Muselet D., Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P.,
RA   Trybou A., Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L., Verdier J.,
RA   Verdier-Discala C., Hillier L.W., Fulton L., McPherson J., Matsuda F.,
RA   Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W., Quetier F.,
RA   Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-312.
RX   PubMed=2469626; DOI=10.1016/0378-1119(88)90182-5;
RA   Hoffmann T., Hovemann B.;
RT   "Heat-shock proteins, Hsp84 and Hsp86, of mice and men: two related genes
RT   encode formerly identified tumour-specific transplantation antigens.";
RL   Gene 74:491-501(1988).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-312.
RX   PubMed=2591742; DOI=10.1016/0378-1119(89)90408-3;
RA   Walter T., Drabent B., Krebs H., Tomalak M., Heiss S., Benecke B.J.J.;
RT   "Cloning and analysis of a human 86-kDa heat-shock-protein-encoding gene.";
RL   Gene 83:105-115(1989).
RN   [11]
RP   PROTEIN SEQUENCE OF 101-112; 210-224; 300-314; 328-338; 346-355; 387-400;
RP   465-478 AND 633-647, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Vishwanath V., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 185-732.
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 539-732.
RC   TISSUE=Heart;
RA   Tanaka M., Tanaka T., Mitsui Y., Yamamoto M., Wood J.N.;
RT   "The analysis of the genes reactive to monoclonal antibody, CE5.";
RL   Submitted (SEP-1996) to the EMBL/GenBank/DDBJ databases.
RN   [14]
RP   PROTEIN SEQUENCE OF 2-21, AND PHOSPHORYLATION AT SER-231 AND SER-263.
RX   PubMed=2492519; DOI=10.1016/s0021-9258(19)81631-9;
RA   Lees-Miller S.P., Anderson C.W.;
RT   "Two human 90-kDa heat shock proteins are phosphorylated in vivo at
RT   conserved serines that are phosphorylated in vitro by casein kinase II.";
RL   J. Biol. Chem. 264:2431-2437(1989).
RN   [15]
RP   PROTEIN SEQUENCE OF 154-163 AND 186-191, AND INTERACTION WITH KSR1.
RX   PubMed=10409742; DOI=10.1128/mcb.19.8.5523;
RA   Stewart S., Sundaram M., Zhang Y., Lee J., Han M., Guan K.L.;
RT   "Kinase suppressor of Ras forms a multiprotein signaling complex and
RT   modulates MEK localization.";
RL   Mol. Cell. Biol. 19:5523-5534(1999).
RN   [16]
RP   PROTEIN SEQUENCE OF 592-612, FUNCTION, CATALYTIC ACTIVITY, MUTAGENESIS OF
RP   CYS-598, AND S-NITROSYLATION AT CYS-598.
RX   PubMed=15937123; DOI=10.1073/pnas.0407294102;
RA   Martinez-Ruiz A., Villanueva L., Gonzalez de Orduna C., Lopez-Ferrer D.,
RA   Higueras M.A., Tarin C., Rodriguez-Crespo I., Vazquez J., Lamas S.;
RT   "S-nitrosylation of Hsp90 promotes the inhibition of its ATPase and
RT   endothelial nitric oxide synthase regulatory activities.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:8525-8530(2005).
RN   [17]
RP   PHOSPHORYLATION AT THR-5 AND THR-7.
RX   PubMed=2507541; DOI=10.1016/s0021-9258(18)71488-9;
RA   Lees-Miller S.P., Anderson C.W.;
RT   "The human double-stranded DNA-activated protein kinase phosphorylates the
RT   90-kDa heat-shock protein, hsp90 alpha at two NH2-terminal threonine
RT   residues.";
RL   J. Biol. Chem. 264:17275-17280(1989).
RN   [18]
RP   HOMODIMERIZATION.
RX   PubMed=8289821; DOI=10.1128/mcb.14.2.1459-1464.1994;
RA   Minami Y., Kimura Y., Kawasaki H., Suzuki K., Yahara I.;
RT   "The carboxy-terminal region of mammalian HSP90 is required for its
RT   dimerization and function in vivo.";
RL   Mol. Cell. Biol. 14:1459-1464(1994).
RN   [19]
RP   SUBUNIT.
RX   PubMed=7588731; DOI=10.1111/j.1432-1033.1995.001_1.x;
RA   Nemoto T., Ohara-Nemoto Y., Ota M., Takagi T., Yokoyama K.;
RT   "Mechanism of dimer formation of the 90-kDa heat-shock protein.";
RL   Eur. J. Biochem. 233:1-8(1995).
RN   [20]
RP   IDENTIFICATION IN A COMPLEX WITH NR3C1 AND FKBP4; PPID; PPP5C OR STIP1.
RX   PubMed=9195923; DOI=10.1074/jbc.272.26.16224;
RA   Silverstein A.M., Galigniana M.D., Chen M.S., Owens-Grillo J.K.,
RA   Chinkers M., Pratt W.B.;
RT   "Protein phosphatase 5 is a major component of glucocorticoid
RT   receptor.hsp90 complexes with properties of an FK506-binding
RT   immunophilin.";
RL   J. Biol. Chem. 272:16224-16230(1997).
RN   [21]
RP   INTERACTION WITH TOM34.
RX   PubMed=9660753; DOI=10.1074/jbc.273.29.18007;
RA   Young J.C., Obermann W.M., Hartl F.U.;
RT   "Specific binding of tetratricopeptide repeat proteins to the C-terminal
RT   12-kDa domain of hsp90.";
RL   J. Biol. Chem. 273:18007-18010(1998).
RN   [22]
RP   IDENTIFICATION AS A RENAL CANCER ANTIGEN.
RC   TISSUE=Renal cell carcinoma;
RX   PubMed=10508479;
RX   DOI=10.1002/(sici)1097-0215(19991112)83:4<456::aid-ijc4>3.0.co;2-5;
RA   Scanlan M.J., Gordan J.D., Williamson B., Stockert E., Bander N.H.,
RA   Jongeneel C.V., Gure A.O., Jaeger D., Jaeger E., Knuth A., Chen Y.-T.,
RA   Old L.J.;
RT   "Antigens recognized by autologous antibody in patients with renal-cell
RT   carcinoma.";
RL   Int. J. Cancer 83:456-464(1999).
RN   [23]
RP   INTERACTION WITH TERT, AND FUNCTION AS A CO-CHAPERONE IN TELOMERASE
RP   HOLOENZYME ASSEMBLY.
RX   PubMed=11274138; DOI=10.1074/jbc.c100055200;
RA   Forsythe H.L., Jarvis J.L., Turner J.W., Elmore L.W., Holt S.E.;
RT   "Stable association of hsp90 and p23, but Not hsp70, with active human
RT   telomerase.";
RL   J. Biol. Chem. 276:15571-15574(2001).
RN   [24]
RP   INTERACTION WITH HSF1.
RX   PubMed=11583998; DOI=10.1074/jbc.m105931200;
RA   Guo Y., Guettouche T., Fenna M., Boellmann F., Pratt W.B., Toft D.O.,
RA   Smith D.F., Voellmy R.;
RT   "Evidence for a mechanism of repression of heat shock factor 1
RT   transcriptional activity by a multichaperone complex.";
RL   J. Biol. Chem. 276:45791-45799(2001).
RN   [25]
RP   FUNCTION, IDENTIFICATION AS LPS RECEPTOR, INTERACTION WITH CXCR4; GDF5 AND
RP   HSPA8, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=11276205; DOI=10.1038/86342;
RA   Triantafilou K., Triantafilou M., Dedrick R.L.;
RT   "A CD14-independent LPS receptor cluster.";
RL   Nat. Immunol. 2:338-345(2001).
RN   [26]
RP   FUNCTION, INTERACTION WITH TOMM70, AND CATALYTIC ACTIVITY.
RX   PubMed=12526792; DOI=10.1016/s0092-8674(02)01250-3;
RA   Young J.C., Hoogenraad N.J., Hartl F.U.;
RT   "Molecular chaperones Hsp90 and Hsp70 deliver preproteins to the
RT   mitochondrial import receptor Tom70.";
RL   Cell 112:41-50(2003).
RN   [27]
RP   INTERACTION WITH DNAJC7.
RX   PubMed=12853476; DOI=10.1093/emboj/cdg362;
RA   Brychzy A., Rein T., Winklhofer K.F., Hartl F.U., Young J.C.,
RA   Obermann W.M.;
RT   "Cofactor Tpr2 combines two TPR domains and a J domain to regulate the
RT   Hsp70/Hsp90 chaperone system.";
RL   EMBO J. 22:3613-3623(2003).
RN   [28]
RP   INTERACTION WITH AHSA1.
RX   PubMed=12604615; DOI=10.1074/jbc.m212761200;
RA   Lotz G.P., Lin H., Harst A., Obermann W.M.J.;
RT   "Aha1 binds to the middle domain of Hsp90, contributes to client protein
RT   activation, and stimulates the ATPase activity of the molecular
RT   chaperone.";
RL   J. Biol. Chem. 278:17228-17235(2003).
RN   [29]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Lymphoblast;
RX   PubMed=14654843; DOI=10.1038/nature02166;
RA   Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A., Mann M.;
RT   "Proteomic characterization of the human centrosome by protein correlation
RT   profiling.";
RL   Nature 426:570-574(2003).
RN   [30]
RP   INTERACTION WITH SMYD3.
RX   PubMed=15235609; DOI=10.1038/ncb1151;
RA   Hamamoto R., Furukawa Y., Morita M., Iimura Y., Silva F.P., Li M.,
RA   Yagyu R., Nakamura Y.;
RT   "SMYD3 encodes a histone methyltransferase involved in the proliferation of
RT   cancer cells.";
RL   Nat. Cell Biol. 6:731-740(2004).
RN   [31]
RP   INTERACTION WITH SGTA AND TTC1.
RX   PubMed=15708368; DOI=10.1016/j.abb.2004.12.020;
RA   Liou S.T., Wang C.;
RT   "Small glutamine-rich tetratricopeptide repeat-containing protein is
RT   composed of three structural units with distinct functions.";
RL   Arch. Biochem. Biophys. 435:253-263(2005).
RN   [32]
RP   INTERACTION WITH PPP5C, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=15383005; DOI=10.1042/bj20040690;
RA   Zeke T., Morrice N., Vazquez-Martin C., Cohen P.T.;
RT   "Human protein phosphatase 5 dissociates from heat-shock proteins and is
RT   proteolytically activated in response to arachidonic acid and the
RT   microtubule-depolymerizing drug nocodazole.";
RL   Biochem. J. 385:45-56(2005).
RN   [33]
RP   FUNCTION, AND INTERACTION WITH PPP5C.
RX   PubMed=15577939; DOI=10.1038/sj.emboj.7600496;
RA   Yang J., Roe S.M., Cliff M.J., Williams M.A., Ladbury J.E., Cohen P.T.,
RA   Barford D.;
RT   "Molecular basis for TPR domain-mediated regulation of protein phosphatase
RT   5.";
RL   EMBO J. 24:1-10(2005).
RN   [34]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-231 AND SER-263, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [35]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-263, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Pituitary;
RX   PubMed=16807684; DOI=10.1007/s11102-006-8916-x;
RA   Beranova-Giorgianni S., Zhao Y., Desiderio D.M., Giorgianni F.;
RT   "Phosphoproteomic analysis of the human pituitary.";
RL   Pituitary 9:109-120(2006).
RN   [36]
RP   INTERACTION WITH PPP5C.
RX   PubMed=16531226; DOI=10.1016/j.str.2005.12.009;
RA   Cliff M.J., Harris R., Barford D., Ladbury J.E., Williams M.A.;
RT   "Conformational diversity in the TPR domain-mediated interaction of protein
RT   phosphatase 5 with Hsp90.";
RL   Structure 14:415-426(2006).
RN   [37]
RP   INTERACTION WITH NLRP12.
RX   PubMed=17947705; DOI=10.4049/jimmunol.179.9.6291;
RA   Arthur J.C., Lich J.D., Aziz R.K., Kotb M., Ting J.P.;
RT   "Heat shock protein 90 associates with monarch-1 and regulates its ability
RT   to promote degradation of NF-kappaB-inducing kinase.";
RL   J. Immunol. 179:6291-6296(2007).
RN   [38]
RP   SUBUNIT, ACTIVITY REGULATION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=18400751; DOI=10.1074/jbc.m800540200;
RA   Richter K., Soroka J., Skalniak L., Leskovar A., Hessling M., Reinstein J.,
RA   Buchner J.;
RT   "Conserved conformational changes in the ATPase cycle of human Hsp90.";
RL   J. Biol. Chem. 283:17757-17765(2008).
RN   [39]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-263, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=T-cell;
RX   PubMed=19367720; DOI=10.1021/pr800500r;
RA   Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
RT   "Phosphorylation analysis of primary human T lymphocytes using sequential
RT   IMAC and titanium oxide enrichment.";
RL   J. Proteome Res. 7:5167-5176(2008).
RN   [40]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-252 AND SER-263, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [41]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-263, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [42]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-263, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [43]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-231 AND SER-263, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by enrichment
RT   and fractionation of phosphopeptides with strong anion exchange
RT   chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [44]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [45]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [46]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-443; LYS-458; LYS-489 AND
RP   LYS-585, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [47]
RP   INTERACTION WITH CHORDC1.
RX   PubMed=19875381; DOI=10.1074/mcp.m900261-mcp200;
RA   Gano J.J., Simon J.A.;
RT   "A proteomic investigation of ligand-dependent HSP90 complexes reveals
RT   CHORDC1 as a novel ADP-dependent HSP90-interacting protein.";
RL   Mol. Cell. Proteomics 9:255-270(2010).
RN   [48]
RP   ISGYLATION.
RX   PubMed=16139798; DOI=10.1016/j.bbrc.2005.08.132;
RA   Giannakopoulos N.V., Luo J.K., Papov V., Zou W., Lenschow D.J.,
RA   Jacobs B.S., Borden E.C., Li J., Virgin H.W., Zhang D.E.;
RT   "Proteomic identification of proteins conjugated to ISG15 in mouse and
RT   human cells.";
RL   Biochem. Biophys. Res. Commun. 336:496-506(2005).
RN   [49]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H., Mangini N.J.,
RA   Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R., Yamagishi S.,
RA   Shabanowitz J., Hearing V.J., Wu C., Appella E., Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [50]
RP   INTERACTION WITH FNIP1, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=17028174; DOI=10.1073/pnas.0603781103;
RA   Baba M., Hong S.-B., Sharma N., Warren M.B., Nickerson M.L., Iwamatsu A.,
RA   Esposito D., Gillette W.K., Hopkins R.F. III, Hartley J.L., Furihata M.,
RA   Oishi S., Zhen W., Burke T.R. Jr., Linehan W.M., Schmidt L.S., Zbar B.;
RT   "Folliculin encoded by the BHD gene interacts with a binding protein,
RT   FNIP1, and AMPK, and is involved in AMPK and mTOR signaling.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:15552-15557(2006).
RN   [51]
RP   MUTAGENESIS OF GLY-97.
RX   PubMed=18256191; DOI=10.1242/dev.018150;
RA   Hawkins T.A., Haramis A.P., Etard C., Prodromou C., Vaughan C.K.,
RA   Ashworth R., Ray S., Behra M., Holder N., Talbot W.S., Pearl L.H.,
RA   Strahle U., Wilson S.W.;
RT   "The ATPase-dependent chaperoning activity of Hsp90a regulates thick
RT   filament formation and integration during skeletal muscle
RT   myofibrillogenesis.";
RL   Development 135:1147-1156(2008).
RN   [52]
RP   MUTAGENESIS OF CYS-598.
RX   PubMed=19696785; DOI=10.1038/embor.2009.153;
RA   Retzlaff M., Stahl M., Eberl H.C., Lagleder S., Beck J., Kessler H.,
RA   Buchner J.;
RT   "Hsp90 is regulated by a switch point in the C-terminal domain.";
RL   EMBO Rep. 10:1147-1153(2009).
RN   [53]
RP   FUNCTION, INTERACTION WITH TOMM70; IRF3 AND TBK1, AND MUTAGENESIS OF
RP   729-GLU--ASP-732.
RX   PubMed=20628368; DOI=10.1038/cr.2010.103;
RA   Liu X.Y., Wei B., Shi H.X., Shan Y.F., Wang C.;
RT   "Tom70 mediates activation of interferon regulatory factor 3 on
RT   mitochondria.";
RL   Cell Res. 20:994-1011(2010).
RN   [54]
RP   INTERACTION WITH HSP90AB1.
RX   PubMed=20353823; DOI=10.1016/j.cellsig.2010.03.012;
RA   Cheng M.B., Zhang Y., Zhong X., Sutter B., Cao C.Y., Chen X.S., Cheng X.K.,
RA   Zhang Y., Xiao L., Shen Y.F.;
RT   "Stat1 mediates an auto-regulation of hsp90beta gene in heat shock
RT   response.";
RL   Cell. Signal. 22:1206-1213(2010).
RN   [55]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [56]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [57]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-252, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [58]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH N.MENINGITIDIS ADHESIN
RP   A (MICROBIAL INFECTION).
RX   PubMed=22066472; DOI=10.1111/j.1462-5822.2011.01722.x;
RA   Montanari P., Bozza G., Capecchi B., Caproni E., Barrile R., Norais N.,
RA   Capitani M., Sallese M., Cecchini P., Ciucchi L., Gao Z., Rappuoli R.,
RA   Pizza M., Arico B., Merola M.;
RT   "Human heat shock protein (Hsp) 90 interferes with Neisseria meningitidis
RT   adhesin A (NadA)-mediated adhesion and invasion.";
RL   Cell. Microbiol. 14:368-385(2012).
RN   [59]
RP   INTERACTION WITH CDC37.
RX   PubMed=23569206; DOI=10.1074/jbc.m112.439257;
RA   Eckl J.M., Rutz D.A., Haslbeck V., Zierer B.K., Reinstein J., Richter K.;
RT   "Cdc37 (cell division cycle 37) restricts Hsp90 (heat shock protein 90)
RT   motility by interaction with N-terminal and middle domain binding sites.";
RL   J. Biol. Chem. 288:16032-16042(2013).
RN   [60]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-231; SER-252; SER-263;
RP   SER-476 AND SER-641, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [61]
RP   FUNCTION, AND INTERACTION WITH STUB1 AND SMAD3.
RX   PubMed=24613385; DOI=10.1016/j.bbrc.2014.02.124;
RA   Shang Y., Xu X., Duan X., Guo J., Wang Y., Ren F., He D., Chang Z.;
RT   "Hsp70 and Hsp90 oppositely regulate TGF-beta signaling through
RT   CHIP/Stub1.";
RL   Biochem. Biophys. Res. Commun. 446:387-392(2014).
RN   [62]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-231, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [63]
RP   INTERACTION WITH NWD1.
RX   PubMed=24681825; DOI=10.18632/oncotarget.1850;
RA   Correa R.G., Krajewska M., Ware C.F., Gerlic M., Reed J.C.;
RT   "The NLR-related protein NWD1 is associated with prostate cancer and
RT   modulates androgen receptor signaling.";
RL   Oncotarget 5:1666-1682(2014).
RN   [64]
RP   REVIEW.
RX   PubMed=25973397; DOI=10.3389/fonc.2015.00100;
RA   Khurana N., Bhattacharyya S.;
RT   "Hsp90, the concertmaster: tuning transcription.";
RL   Front. Oncol. 5:100-100(2015).
RN   [65]
RP   FUNCTION, INTERACTION WITH TOMM70 AND IRF3, SUBCELLULAR LOCATION, AND
RP   MUTAGENESIS OF 728-MET--ASP-732.
RX   PubMed=25609812; DOI=10.1128/jvi.02959-14;
RA   Wei B., Cui Y., Huang Y., Liu H., Li L., Li M., Ruan K.C., Zhou Q.,
RA   Wang C.;
RT   "Tom70 mediates Sendai virus-induced apoptosis on mitochondria.";
RL   J. Virol. 89:3804-3818(2015).
RN   [66]
RP   INTERACTION WITH SMYD3.
RX   PubMed=25738358; DOI=10.18632/oncotarget.2970;
RA   Brown M.A., Foreman K., Harriss J., Das C., Zhu L., Edwards M., Shaaban S.,
RA   Tucker H.;
RT   "C-terminal domain of SMYD3 serves as a unique HSP90-regulated motif in
RT   oncogenesis.";
RL   Oncotarget 6:4005-4019(2015).
RN   [67]
RP   INTERACTION WITH HSF1; HIF1A; ERBB2; MET; KEAP1 AND RHOBTB2, AND
RP   MUTAGENESIS OF GLU-47 AND ASP-93.
RX   PubMed=26517842; DOI=10.1371/journal.pone.0141786;
RA   Prince T.L., Kijima T., Tatokoro M., Lee S., Tsutsumi S., Yim K., Rivas C.,
RA   Alarcon S., Schwartz H., Khamit-Kush K., Scroggins B.T., Beebe K.,
RA   Trepel J.B., Neckers L.;
RT   "Client proteins and small molecule inhibitors display distinct binding
RT   preferences for constitutive and stress-induced HSP90 isoforms and their
RT   conformationally restricted mutants.";
RL   PLoS ONE 10:E0141786-E0141786(2015).
RN   [68]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [69]
RP   REVIEW.
RX   PubMed=27295069; DOI=10.1016/j.biochi.2016.05.018;
RA   Verma S., Goyal S., Jamal S., Singh A., Grover A.;
RT   "Hsp90: Friends, clients and natural foes.";
RL   Biochimie 127:227-240(2016).
RN   [70]
RP   REVIEW.
RX   PubMed=26991466; DOI=10.1002/bip.22835;
RA   Pearl L.H.;
RT   "Review: The HSP90 molecular chaperone-an enigmatic ATPase.";
RL   Biopolymers 105:594-607(2016).
RN   [71]
RP   FUNCTION, AND INTERACTION WITH FLCN; AHSA1; HSP70; CDC37; FNIP1; FNIP2;
RP   STUB1; STIP1; PTGES3 AND PPP5C.
RX   PubMed=27353360; DOI=10.1038/ncomms12037;
RA   Woodford M.R., Dunn D.M., Blanden A.R., Capriotti D., Loiselle D.,
RA   Prodromou C., Panaretou B., Hughes P.F., Smith A., Ackerman W.,
RA   Haystead T.A., Loh S.N., Bourboulia D., Schmidt L.S., Marston Linehan W.,
RA   Bratslavsky G., Mollapour M.;
RT   "The FNIP co-chaperones decelerate the Hsp90 chaperone cycle and enhance
RT   drug binding.";
RL   Nat. Commun. 7:12037-12037(2016).
RN   [72]
RP   INTERACTION WITH HSF1.
RX   PubMed=26754925; DOI=10.1038/srep19174;
RA   Asano Y., Kawase T., Okabe A., Tsutsumi S., Ichikawa H., Tatebe S.,
RA   Kitabayashi I., Tashiro F., Namiki H., Kondo T., Semba K., Aburatani H.,
RA   Taya Y., Nakagama H., Ohki R.;
RT   "IER5 generates a novel hypo-phosphorylated active form of HSF1 and
RT   contributes to tumorigenesis.";
RL   Sci. Rep. 6:19174-19174(2016).
RN   [73]
RP   FUNCTION, ACTIVITY REGULATION, IDENTIFICATION IN A COMPLEX WITH TSC1 AND
RP   TSC2, INTERACTION WITH TSC1 AND AHSA1, SUBUNIT, AND MUTAGENESIS OF GLU-47;
RP   ASP-93; TYR-313 AND 728-MET--ASP-732.
RX   PubMed=29127155; DOI=10.15252/embj.201796700;
RA   Woodford M.R., Sager R.A., Marris E., Dunn D.M., Blanden A.R., Murphy R.L.,
RA   Rensing N., Shapiro O., Panaretou B., Prodromou C., Loh S.N., Gutmann D.H.,
RA   Bourboulia D., Bratslavsky G., Wong M., Mollapour M.;
RT   "Tumor suppressor Tsc1 is a new Hsp90 co-chaperone that facilitates folding
RT   of kinase and non-kinase clients.";
RL   EMBO J. 36:3650-3665(2017).
RN   [74]
RP   INTERACTION WITH NLRP12.
RX   PubMed=30559449; DOI=10.1038/s41467-018-07750-5;
RA   Normand S., Waldschmitt N., Neerincx A., Martinez-Torres R.J., Chauvin C.,
RA   Couturier-Maillard A., Boulard O., Cobret L., Awad F., Huot L.,
RA   Ribeiro-Ribeiro A., Lautz K., Ruez R., Delacre M., Bondu C., Guilliams M.,
RA   Scott C., Segal A., Amselem S., Hot D., Karabina S., Bohn E., Ryffel B.,
RA   Poulin L.F., Kufer T.A., Chamaillard M.;
RT   "Proteasomal degradation of NOD2 by NLRP12 in monocytes promotes bacterial
RT   tolerance and colonization by enteropathogens.";
RL   Nat. Commun. 9:5338-5338(2018).
RN   [75]
RP   INTERACTION WITH HERPES SIMPLEX VIRUS 1 PROTEIN US11 (MICROBIAL INFECTION).
RX   PubMed=29743370; DOI=10.1128/jvi.00402-18;
RA   Liu X., Main D., Ma Y., He B.;
RT   "Herpes Simplex Virus 1 Inhibits TANK-Binding Kinase 1 through Formation of
RT   the Us11-Hsp90 Complex.";
RL   J. Virol. 92:0-0(2018).
RN   [76]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 11-223 IN COMPLEX WITH
RP   GELDANAMYCIN.
RX   PubMed=9108479; DOI=10.1016/s0092-8674(00)80203-2;
RA   Stebbins C.E., Russo A.A., Schneider C., Rosen N., Hartl F.U.,
RA   Pavletich N.P.;
RT   "Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein
RT   chaperone by an antitumor agent.";
RL   Cell 89:239-250(1997).
RN   [77]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 11-223 IN COMPLEX WITH ADP,
RP   CATALYTIC ACTIVITY, AND INTERACTION WITH PTGES3.
RX   PubMed=9817749; DOI=10.1083/jcb.143.4.901;
RA   Obermann W.M., Sondermann H., Russo A.A., Pavletich N.P., Hartl F.U.;
RT   "In vivo function of Hsp90 is dependent on ATP binding and ATP
RT   hydrolysis.";
RL   J. Cell Biol. 143:901-910(1998).
RN   [78]
RP   X-RAY CRYSTALLOGRAPHY (3.30 ANGSTROMS) OF 724-732 IN COMPLEX WITH STUB1,
RP   INTERACTION WITH STUB1 AND UBE2N, AND MOTIF TPR REPEAT-BINDING.
RX   PubMed=16307917; DOI=10.1016/j.molcel.2005.09.023;
RA   Zhang M., Windheim M., Roe S.M., Peggie M., Cohen P., Prodromou C.,
RA   Pearl L.H.;
RT   "Chaperoned ubiquitylation -- crystal structures of the CHIP U box E3
RT   ubiquitin ligase and a CHIP-Ubc13-Uev1a complex.";
RL   Mol. Cell 20:525-538(2005).
CC   -!- FUNCTION: Molecular chaperone that promotes the maturation, structural
CC       maintenance and proper regulation of specific target proteins involved
CC       for instance in cell cycle control and signal transduction. Undergoes a
CC       functional cycle that is linked to its ATPase activity which is
CC       essential for its chaperone activity. This cycle probably induces
CC       conformational changes in the client proteins, thereby causing their
CC       activation. Interacts dynamically with various co-chaperones that
CC       modulate its substrate recognition, ATPase cycle and chaperone function
CC       (PubMed:11274138, PubMed:12526792, PubMed:15577939, PubMed:15937123,
CC       PubMed:27353360, PubMed:29127155). Engages with a range of client
CC       protein classes via its interaction with various co-chaperone proteins
CC       or complexes, that act as adapters, simultaneously able to interact
CC       with the specific client and the central chaperone itself
CC       (PubMed:29127155). Recruitment of ATP and co-chaperone followed by
CC       client protein forms a functional chaperone. After the completion of
CC       the chaperoning process, properly folded client protein and co-
CC       chaperone leave HSP90 in an ADP-bound partially open conformation and
CC       finally, ADP is released from HSP90 which acquires an open conformation
CC       for the next cycle (PubMed:26991466, PubMed:27295069). Plays a critical
CC       role in mitochondrial import, delivers preproteins to the mitochondrial
CC       import receptor TOMM70 (PubMed:12526792). Apart from its chaperone
CC       activity, it also plays a role in the regulation of the transcription
CC       machinery. HSP90 and its co-chaperones modulate transcription at least
CC       at three different levels (PubMed:25973397). In the first place, they
CC       alter the steady-state levels of certain transcription factors in
CC       response to various physiological cues (PubMed:25973397). Second, they
CC       modulate the activity of certain epigenetic modifiers, such as histone
CC       deacetylases or DNA methyl transferases, and thereby respond to the
CC       change in the environment (PubMed:25973397). Third, they participate in
CC       the eviction of histones from the promoter region of certain genes and
CC       thereby turn on gene expression (PubMed:25973397). Binds bacterial
CC       lipopolysaccharide (LPS) and mediates LPS-induced inflammatory
CC       response, including TNF secretion by monocytes (PubMed:11276205).
CC       Antagonizes STUB1-mediated inhibition of TGF-beta signaling via
CC       inhibition of STUB1-mediated SMAD3 ubiquitination and degradation
CC       (PubMed:24613385). Mediates the association of TOMM70 with IRF3 or TBK1
CC       in mitochondrial outer membrane which promotes host antiviral response
CC       (PubMed:20628368, PubMed:25609812). {ECO:0000269|PubMed:11274138,
CC       ECO:0000269|PubMed:11276205, ECO:0000269|PubMed:12526792,
CC       ECO:0000269|PubMed:15577939, ECO:0000269|PubMed:15937123,
CC       ECO:0000269|PubMed:20628368, ECO:0000269|PubMed:24613385,
CC       ECO:0000269|PubMed:25609812, ECO:0000269|PubMed:27353360,
CC       ECO:0000269|PubMed:29127155, ECO:0000303|PubMed:25973397,
CC       ECO:0000303|PubMed:26991466, ECO:0000303|PubMed:27295069}.
CC   -!- FUNCTION: (Microbial infection) Seems to interfere with N.meningitidis
CC       NadA-mediated invasion of human cells. Decreasing HSP90 levels
CC       increases adhesion and entry of E.coli expressing NadA into human Chang
CC       cells; increasing its levels leads to decreased adhesion and invasion.
CC       {ECO:0000305|PubMed:22066472}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O = ADP + phosphate + H(+); Xref=Rhea:RHEA:13065,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; EC=3.6.4.10;
CC         Evidence={ECO:0000269|PubMed:12526792};
CC   -!- ACTIVITY REGULATION: In the resting state, through the dimerization of
CC       its C-terminal domain, HSP90 forms a homodimer which is defined as the
CC       open conformation (PubMed:18400751). Upon ATP-binding, the N-terminal
CC       domain undergoes significant conformational changes and comes in
CC       contact to form an active closed conformation (PubMed:18400751). After
CC       HSP90 finishes its chaperoning tasks of assisting the proper folding,
CC       stabilization and activation of client proteins under the active state,
CC       ATP molecule is hydrolyzed to ADP which then dissociates from HSP90 and
CC       directs the protein back to the resting state (PubMed:18400751). Co-
CC       chaperone TSC1 promotes ATP binding and inhibits HSP90AA1 ATPase
CC       activity (PubMed:29127155). Binding to phosphorylated AHSA1 promotes
CC       HSP90AA1 ATPase activity (PubMed:29127155). Inhibited by geldanamycin,
CC       Ganetespib (STA-9090) and SNX-2112 (PubMed:12526792, PubMed:29127155).
CC       {ECO:0000269|PubMed:18400751, ECO:0000269|PubMed:29127155}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=300 uM for ATP {ECO:0000269|PubMed:18400751};
CC   -!- SUBUNIT: Homodimer (PubMed:18400751, PubMed:29127155, PubMed:7588731,
CC       PubMed:8289821). Identified in NR3C1/GCR steroid receptor-chaperone
CC       complexes formed at least by NR3C1, HSP90AA1 and a variety of proteins
CC       containing TPR repeats such as FKBP4, FKBP5, PPID, PPP5C or STIP1
CC       (PubMed:15383005, PubMed:9195923). Forms a complex containing HSP90AA1,
CC       TSC1 and TSC2; TSC1 is required to recruit TCS2 to the complex
CC       (PubMed:29127155). The closed form interacts (via the middle domain and
CC       TPR repeat-binding motif) with co-chaperone TSC1 (via C-terminus)
CC       (PubMed:29127155). Interacts with TOM34 (PubMed:9660753). Interacts
CC       with TERT; the interaction, together with PTGES3, is required for
CC       correct assembly and stabilization of the TERT holoenzyme complex
CC       (PubMed:11274138, PubMed:9817749). Interacts with CHORDC1 and DNAJC7
CC       (PubMed:12853476, PubMed:19875381). Interacts with STUB1 and UBE2N; may
CC       couple the chaperone and ubiquitination systems (PubMed:16307917,
CC       PubMed:27353360). Interacts (via TPR repeat-binding motif) with PPP5C
CC       (via TPR repeats); the interaction is direct and activates PPP5C
CC       phosphatase activity (PubMed:15383005, PubMed:15577939,
CC       PubMed:16531226, PubMed:27353360). Following LPS binding, may form a
CC       complex with CXCR4, GDF5 and HSPA8 (PubMed:11276205). Interacts with
CC       KSR1 (PubMed:10409742). Interacts with co-chaperone CDC37 (via C-
CC       terminus); the interaction inhibits HSP90AA1 ATPase activity
CC       (PubMed:23569206, PubMed:27353360). May interact with NWD1
CC       (PubMed:24681825). Interacts with FNIP1 and FNIP2; the interaction
CC       inhibits HSP90AA1 ATPase activity (PubMed:17028174, PubMed:27353360).
CC       Interacts with co-chaperone AHSA1 (phosphorylated on 'Tyr-223'); the
CC       interaction activates HSP90AA1 ATPase activity and results in the
CC       dissociation of TSC1 from HSP90AA1 (PubMed:12604615, PubMed:27353360,
CC       PubMed:29127155). Interacts with FLCN in the presence of FNIP1
CC       (PubMed:27353360). Interacts with HSP70, STIP1 and PTGES3
CC       (PubMed:27353360). Interacts with SMYD3; this interaction enhances
CC       SMYD3 histone-lysine N-methyltransferase (PubMed:15235609,
CC       PubMed:25738358). Interacts with SGTA (via TPR repeats)
CC       (PubMed:15708368). Interacts with TTC1 (via TPR repeats)
CC       (PubMed:15708368). Interacts with HSF1 in an ATP-dependent manner
CC       (PubMed:11583998, PubMed:26517842). Interacts with MET; the interaction
CC       suppresses MET kinase activity (PubMed:26517842). Interacts with ERBB2
CC       in an ATP-dependent manner; the interaction suppresses ERBB2 kinase
CC       activity (PubMed:26517842). Interacts with HIF1A, KEAP1 and RHOBTB2
CC       (PubMed:26517842). Interacts with HSF1; this interaction is decreased
CC       in a IER5-dependent manner, promoting HSF1 accumulation in the nucleus,
CC       homotrimerization and DNA-binding activities (PubMed:26754925).
CC       Interacts with STUB1 and SMAD3 (PubMed:24613385). Interacts with
CC       HSP90AB1; interaction is constitutive (PubMed:20353823). Interacts with
CC       HECTD1 (via N-terminus) (By similarity). Interacts with NR3C1 (via
CC       domain NR LBD) and NR1D1 (via domain NR LBD) (By similarity). Interacts
CC       with NLPR12 (PubMed:17947705, PubMed:30559449). Interacts with PDCL3
CC       (By similarity). Interacts with TOMM70; the interaction is required for
CC       preprotein mitochondrial import (PubMed:12526792). Interacts with
CC       TOMM70, IRF3 and TBK1; the interactions are direct and mediate the
CC       association of TOMM70 with IRF3 and TBK1 (PubMed:20628368). Forms a
CC       complex with ASL, ASS1 and NOS2; the complex regulates cell-autonomous
CC       L-arginine synthesis and citrulline recycling while channeling
CC       extracellular L-arginine to nitric oxide synthesis pathway.
CC       {ECO:0000250|UniProtKB:P07901, ECO:0000250|UniProtKB:P82995,
CC       ECO:0000269|PubMed:10409742, ECO:0000269|PubMed:11274138,
CC       ECO:0000269|PubMed:11276205, ECO:0000269|PubMed:11583998,
CC       ECO:0000269|PubMed:12526792, ECO:0000269|PubMed:12604615,
CC       ECO:0000269|PubMed:12853476, ECO:0000269|PubMed:15235609,
CC       ECO:0000269|PubMed:15383005, ECO:0000269|PubMed:15577939,
CC       ECO:0000269|PubMed:15708368, ECO:0000269|PubMed:16307917,
CC       ECO:0000269|PubMed:16531226, ECO:0000269|PubMed:17028174,
CC       ECO:0000269|PubMed:17947705, ECO:0000269|PubMed:18400751,
CC       ECO:0000269|PubMed:19875381, ECO:0000269|PubMed:20353823,
CC       ECO:0000269|PubMed:20628368, ECO:0000269|PubMed:23569206,
CC       ECO:0000269|PubMed:24613385, ECO:0000269|PubMed:24681825,
CC       ECO:0000269|PubMed:25738358, ECO:0000269|PubMed:26517842,
CC       ECO:0000269|PubMed:26754925, ECO:0000269|PubMed:27353360,
CC       ECO:0000269|PubMed:29127155, ECO:0000269|PubMed:30559449,
CC       ECO:0000269|PubMed:7588731, ECO:0000269|PubMed:8289821,
CC       ECO:0000269|PubMed:9195923, ECO:0000269|PubMed:9660753,
CC       ECO:0000269|PubMed:9817749}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with herpes simplex virus 1
CC       protein US11; this interaction inhibits TBK1-induced interferon
CC       production. {ECO:0000269|PubMed:29743370}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with N.meningitidis serogroup
CC       B adhesin A (nadA). Interaction is stabilized by ADP and 17-AAG (17-N-
CC       allylamino-17-demethoxygeldanamycin) and inhibited by ATP. Decreasing
CC       HSP90 levels increases adhesion and entry of bacterial into human Chang
CC       cells; increasing its levels leads to decreased adhseion and invasion.
CC       {ECO:0000269|PubMed:22066472}.
CC   -!- INTERACTION:
CC       P07900; Q6UY14-3: ADAMTSL4; NbExp=3; IntAct=EBI-296047, EBI-10173507;
CC       P07900; O95433: AHSA1; NbExp=6; IntAct=EBI-296047, EBI-448610;
CC       P07900; Q9Y243: AKT3; NbExp=4; IntAct=EBI-296047, EBI-296115;
CC       P07900; Q16671: AMHR2; NbExp=3; IntAct=EBI-296047, EBI-6423788;
CC       P07900; P05067: APP; NbExp=5; IntAct=EBI-296047, EBI-77613;
CC       P07900; Q9H0C5: BTBD1; NbExp=4; IntAct=EBI-296047, EBI-935503;
CC       P07900; Q9UQM7: CAMK2A; NbExp=5; IntAct=EBI-296047, EBI-1383687;
CC       P07900; Q8IWD4: CCDC117; NbExp=8; IntAct=EBI-296047, EBI-3387963;
CC       P07900; Q9BV29: CCDC32; NbExp=3; IntAct=EBI-296047, EBI-2874058;
CC       P07900; Q16543: CDC37; NbExp=17; IntAct=EBI-296047, EBI-295634;
CC       P07900; Q7L3B6: CDC37L1; NbExp=3; IntAct=EBI-296047, EBI-2841876;
CC       P07900; Q96Q40: CDK15; NbExp=3; IntAct=EBI-296047, EBI-1051975;
CC       P07900; P50750: CDK9; NbExp=6; IntAct=EBI-296047, EBI-1383449;
CC       P07900; Q96G23: CERS2; NbExp=2; IntAct=EBI-296047, EBI-1057080;
CC       P07900; Q9UHD1: CHORDC1; NbExp=8; IntAct=EBI-296047, EBI-2550959;
CC       P07900; O15111: CHUK; NbExp=4; IntAct=EBI-296047, EBI-81249;
CC       P07900; Q6QEF8-4: CORO6; NbExp=3; IntAct=EBI-296047, EBI-10699285;
CC       P07900; Q14194: CRMP1; NbExp=3; IntAct=EBI-296047, EBI-473101;
CC       P07900; P35222: CTNNB1; NbExp=3; IntAct=EBI-296047, EBI-491549;
CC       P07900; Q15438: CYTH1; NbExp=3; IntAct=EBI-296047, EBI-997830;
CC       P07900; Q9NR20: DYRK4; NbExp=2; IntAct=EBI-296047, EBI-3914009;
CC       P07900; P00533: EGFR; NbExp=8; IntAct=EBI-296047, EBI-297353;
CC       P07900; P07814: EPRS1; NbExp=2; IntAct=EBI-296047, EBI-355315;
CC       P07900; P04626: ERBB2; NbExp=6; IntAct=EBI-296047, EBI-641062;
CC       P07900; Q02790: FKBP4; NbExp=9; IntAct=EBI-296047, EBI-1047444;
CC       P07900; Q13451: FKBP5; NbExp=9; IntAct=EBI-296047, EBI-306914;
CC       P07900; Q14318: FKBP8; NbExp=8; IntAct=EBI-296047, EBI-724839;
CC       P07900; P06241: FYN; NbExp=8; IntAct=EBI-296047, EBI-515315;
CC       P07900; Q96LI6-3: HSFY2; NbExp=3; IntAct=EBI-296047, EBI-25830912;
CC       P07900; P07900: HSP90AA1; NbExp=6; IntAct=EBI-296047, EBI-296047;
CC       P07900; Q6PK50: HSP90AB1; NbExp=2; IntAct=EBI-296047, EBI-9356629;
CC       P07900; Q9Y6K9: IKBKG; NbExp=4; IntAct=EBI-296047, EBI-81279;
CC       P07900; Q9UHH9: IP6K2; NbExp=2; IntAct=EBI-296047, EBI-747509;
CC       P07900; P05412: JUN; NbExp=4; IntAct=EBI-296047, EBI-852823;
CC       P07900; Q92993-2: KAT5; NbExp=3; IntAct=EBI-296047, EBI-20795332;
CC       P07900; Q6VAB6: KSR2; NbExp=6; IntAct=EBI-296047, EBI-6424389;
CC       P07900; P06239: LCK; NbExp=3; IntAct=EBI-296047, EBI-1348;
CC       P07900; Q99558: MAP3K14; NbExp=5; IntAct=EBI-296047, EBI-358011;
CC       P07900; O43318-2: MAP3K7; NbExp=5; IntAct=EBI-296047, EBI-358700;
CC       P07900; P00540: MOS; NbExp=2; IntAct=EBI-296047, EBI-1757866;
CC       P07900; Q9Y239: NOD1; NbExp=2; IntAct=EBI-296047, EBI-1051262;
CC       P07900; P04150: NR3C1; NbExp=8; IntAct=EBI-296047, EBI-493507;
CC       P07900; Q8WVJ2: NUDCD2; NbExp=4; IntAct=EBI-296047, EBI-1052153;
CC       P07900; P43034: PAFAH1B1; NbExp=5; IntAct=EBI-296047, EBI-720620;
CC       P07900; P53041: PPP5C; NbExp=13; IntAct=EBI-296047, EBI-716663;
CC       P07900; P17612: PRKACA; NbExp=4; IntAct=EBI-296047, EBI-476586;
CC       P07900; Q8WUY3: PRUNE2; NbExp=3; IntAct=EBI-296047, EBI-743880;
CC       P07900; Q96QS6: PSKH2; NbExp=3; IntAct=EBI-296047, EBI-6424813;
CC       P07900; Q15185: PTGES3; NbExp=9; IntAct=EBI-296047, EBI-1049387;
CC       P07900; P04049: RAF1; NbExp=15; IntAct=EBI-296047, EBI-365996;
CC       P07900; Q13127: REST; NbExp=4; IntAct=EBI-296047, EBI-926706;
CC       P07900; Q9H6T3: RPAP3; NbExp=7; IntAct=EBI-296047, EBI-356928;
CC       P07900; P61247: RPS3A; NbExp=3; IntAct=EBI-296047, EBI-352378;
CC       P07900; P12931: SRC; NbExp=3; IntAct=EBI-296047, EBI-621482;
CC       P07900; Q15831: STK11; NbExp=6; IntAct=EBI-296047, EBI-306838;
CC       P07900; Q9UNE7: STUB1; NbExp=9; IntAct=EBI-296047, EBI-357085;
CC       P07900; Q15750: TAB1; NbExp=2; IntAct=EBI-296047, EBI-358643;
CC       P07900; Q9NYJ8: TAB2; NbExp=2; IntAct=EBI-296047, EBI-358708;
CC       P07900; O94826: TOMM70; NbExp=4; IntAct=EBI-296047, EBI-2800236;
CC       P07900; Q9BXA6: TSSK6; NbExp=5; IntAct=EBI-296047, EBI-851883;
CC       P07900; P10599: TXN; NbExp=3; IntAct=EBI-296047, EBI-594644;
CC       P07900; Q8IWX7: UNC45B; NbExp=3; IntAct=EBI-296047, EBI-9363363;
CC       P07900; Q9H6R7-2: WDCP; NbExp=3; IntAct=EBI-296047, EBI-25833271;
CC       P07900; Q9D1P4: Chordc1; Xeno; NbExp=3; IntAct=EBI-296047, EBI-7448218;
CC       P07900; P26882: PPID; Xeno; NbExp=4; IntAct=EBI-296047, EBI-6477155;
CC       P07900; P35467: S100a1; Xeno; NbExp=4; IntAct=EBI-296047, EBI-6477109;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P07901}. Cytoplasm
CC       {ECO:0000250|UniProtKB:P07901}. Melanosome
CC       {ECO:0000269|PubMed:17081065}. Cell membrane
CC       {ECO:0000269|PubMed:11276205}. Mitochondrion
CC       {ECO:0000269|PubMed:25609812}. Note=Identified by mass spectrometry in
CC       melanosome fractions from stage I to stage IV.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=HSP90AA1-1, HSP90-alpha 2;
CC         IsoId=P07900-1; Sequence=Displayed;
CC       Name=2; Synonyms=HSP90AA1-2;
CC         IsoId=P07900-2; Sequence=VSP_026604;
CC   -!- DOMAIN: The TPR repeat-binding motif mediates interaction with TPR
CC       repeat-containing proteins like the co-chaperone STUB1.
CC       {ECO:0000269|PubMed:16307917}.
CC   -!- PTM: ISGylated. {ECO:0000269|PubMed:16139798}.
CC   -!- PTM: S-nitrosylated; negatively regulates the ATPase activity and the
CC       activation of eNOS by HSP90AA1. {ECO:0000269|PubMed:15937123}.
CC   -!- PTM: Ubiquitinated via 'Lys-63'-linked polyubiquitination by HECTD1.
CC       Ubiquitination promotes translocation into the cytoplasm away from the
CC       membrane and secretory pathways. {ECO:0000250|UniProtKB:P07901}.
CC   -!- SIMILARITY: Belongs to the heat shock protein 90 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X15183; CAA33259.1; -; mRNA.
DR   EMBL; M27024; AAA63194.1; -; Genomic_DNA.
DR   EMBL; AJ890082; CAI64495.1; -; mRNA.
DR   EMBL; AJ890083; CAI64496.1; -; mRNA.
DR   EMBL; DQ314871; ABC40730.1; -; Genomic_DNA.
DR   EMBL; AK056446; BAG51711.1; -; mRNA.
DR   EMBL; AK291115; BAF83804.1; -; mRNA.
DR   EMBL; AK291607; BAF84296.1; -; mRNA.
DR   EMBL; AL133223; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471061; EAW81765.1; -; Genomic_DNA.
DR   EMBL; X07270; CAA30255.1; -; mRNA.
DR   EMBL; M30626; AAA36023.1; -; Genomic_DNA.
DR   EMBL; BC000987; AAH00987.1; -; mRNA.
DR   EMBL; BC121062; AAI21063.1; -; mRNA.
DR   EMBL; D87666; BAA13430.1; -; mRNA.
DR   EMBL; D87666; BAA13431.1; -; mRNA.
DR   CCDS; CCDS32160.1; -. [P07900-2]
DR   CCDS; CCDS9967.1; -. [P07900-1]
DR   PIR; A32319; HHHU86.
DR   RefSeq; NP_001017963.2; NM_001017963.3. [P07900-2]
DR   RefSeq; NP_005339.3; NM_005348.3. [P07900-1]
DR   PDB; 1BYQ; X-ray; 1.50 A; A=9-236.
DR   PDB; 1OSF; X-ray; 1.75 A; A=9-223.
DR   PDB; 1UY6; X-ray; 1.90 A; A=2-236.
DR   PDB; 1UY7; X-ray; 1.90 A; A=2-236.
DR   PDB; 1UY8; X-ray; 1.98 A; A=2-236.
DR   PDB; 1UY9; X-ray; 2.00 A; A=2-236.
DR   PDB; 1UYC; X-ray; 2.00 A; A=2-236.
DR   PDB; 1UYD; X-ray; 2.20 A; A=2-236.
DR   PDB; 1UYE; X-ray; 2.00 A; A=2-236.
DR   PDB; 1UYF; X-ray; 2.00 A; A=2-236.
DR   PDB; 1UYG; X-ray; 2.00 A; A=2-236.
DR   PDB; 1UYH; X-ray; 2.20 A; A=2-236.
DR   PDB; 1UYI; X-ray; 2.20 A; A=2-236.
DR   PDB; 1UYK; X-ray; 2.20 A; A=2-236.
DR   PDB; 1UYL; X-ray; 1.40 A; A=2-236.
DR   PDB; 1YC1; X-ray; 1.70 A; A=9-236.
DR   PDB; 1YC3; X-ray; 2.12 A; A=9-236.
DR   PDB; 1YC4; X-ray; 1.81 A; A=9-236.
DR   PDB; 1YER; X-ray; 1.65 A; A=9-236.
DR   PDB; 1YES; X-ray; 2.20 A; A=9-236.
DR   PDB; 1YET; X-ray; 1.90 A; A=9-236.
DR   PDB; 2BSM; X-ray; 2.05 A; A=2-236.
DR   PDB; 2BT0; X-ray; 1.90 A; A/B=2-236.
DR   PDB; 2BUG; NMR; -; B=728-732.
DR   PDB; 2BYH; X-ray; 1.90 A; A=11-236.
DR   PDB; 2BYI; X-ray; 1.60 A; A=11-236.
DR   PDB; 2BZ5; X-ray; 1.90 A; A/B=2-236.
DR   PDB; 2C2L; X-ray; 3.30 A; E/F/G/H=724-732.
DR   PDB; 2CCS; X-ray; 1.79 A; A=1-236.
DR   PDB; 2CCT; X-ray; 2.30 A; A=1-236.
DR   PDB; 2CCU; X-ray; 2.70 A; A=1-236.
DR   PDB; 2FWY; X-ray; 2.10 A; A=1-236.
DR   PDB; 2FWZ; X-ray; 2.10 A; A=1-236.
DR   PDB; 2H55; X-ray; 2.00 A; A=1-236.
DR   PDB; 2JJC; X-ray; 1.95 A; A=9-223.
DR   PDB; 2K5B; NMR; -; A=14-223.
DR   PDB; 2QF6; X-ray; 3.10 A; A/B/C/D=17-223.
DR   PDB; 2QFO; X-ray; 1.68 A; A/B=17-223.
DR   PDB; 2QG0; X-ray; 1.85 A; A/B=17-223.
DR   PDB; 2QG2; X-ray; 1.80 A; A=17-223.
DR   PDB; 2UWD; X-ray; 1.90 A; A=2-236.
DR   PDB; 2VCI; X-ray; 2.00 A; A=1-236.
DR   PDB; 2VCJ; X-ray; 2.50 A; A=1-236.
DR   PDB; 2WI1; X-ray; 2.30 A; A=1-236.
DR   PDB; 2WI2; X-ray; 2.09 A; A/B=1-236.
DR   PDB; 2WI3; X-ray; 1.90 A; A=1-236.
DR   PDB; 2WI4; X-ray; 2.40 A; A=1-236.
DR   PDB; 2WI5; X-ray; 2.10 A; A=1-236.
DR   PDB; 2WI6; X-ray; 2.18 A; A=1-236.
DR   PDB; 2WI7; X-ray; 2.50 A; A=1-236.
DR   PDB; 2XAB; X-ray; 1.90 A; A/B=9-236.
DR   PDB; 2XDK; X-ray; 1.97 A; A=9-236.
DR   PDB; 2XDL; X-ray; 1.98 A; A=9-236.
DR   PDB; 2XDS; X-ray; 1.97 A; A=9-236.
DR   PDB; 2XDU; X-ray; 1.74 A; A=14-224.
DR   PDB; 2XDX; X-ray; 2.42 A; A=9-236.
DR   PDB; 2XHR; X-ray; 2.20 A; A=9-236.
DR   PDB; 2XHT; X-ray; 2.27 A; A=9-236.
DR   PDB; 2XHX; X-ray; 2.80 A; A=9-236.
DR   PDB; 2XJG; X-ray; 2.25 A; A=9-236.
DR   PDB; 2XJJ; X-ray; 1.90 A; A/B=9-236.
DR   PDB; 2XJX; X-ray; 1.66 A; A=9-236.
DR   PDB; 2XK2; X-ray; 1.95 A; A=9-236.
DR   PDB; 2YE2; X-ray; 1.90 A; A=9-236.
DR   PDB; 2YE3; X-ray; 1.95 A; A=9-236.
DR   PDB; 2YE4; X-ray; 2.30 A; A=9-236.
DR   PDB; 2YE5; X-ray; 1.73 A; A=9-236.
DR   PDB; 2YE6; X-ray; 2.56 A; A=9-236.
DR   PDB; 2YE7; X-ray; 2.20 A; A=9-236.
DR   PDB; 2YE8; X-ray; 2.30 A; A=9-236.
DR   PDB; 2YE9; X-ray; 2.20 A; A=9-236.
DR   PDB; 2YEA; X-ray; 1.73 A; A=9-236.
DR   PDB; 2YEB; X-ray; 2.40 A; A=9-236.
DR   PDB; 2YEC; X-ray; 2.10 A; A=9-236.
DR   PDB; 2YED; X-ray; 2.10 A; A=9-236.
DR   PDB; 2YEE; X-ray; 2.30 A; A=9-236.
DR   PDB; 2YEF; X-ray; 1.55 A; A=9-236.
DR   PDB; 2YEG; X-ray; 2.50 A; A/B=9-236.
DR   PDB; 2YEH; X-ray; 2.10 A; A=9-236.
DR   PDB; 2YEI; X-ray; 2.20 A; A=9-236.
DR   PDB; 2YEJ; X-ray; 2.20 A; A=9-236.
DR   PDB; 2YI0; X-ray; 1.60 A; A=1-229.
DR   PDB; 2YI5; X-ray; 2.50 A; A=1-229.
DR   PDB; 2YI6; X-ray; 1.80 A; A=1-229.
DR   PDB; 2YI7; X-ray; 1.40 A; A=1-229.
DR   PDB; 2YJW; X-ray; 1.61 A; A=18-223.
DR   PDB; 2YJX; X-ray; 1.83 A; A=18-223.
DR   PDB; 2YK2; X-ray; 1.74 A; A=18-223.
DR   PDB; 2YK9; X-ray; 1.32 A; A=18-223.
DR   PDB; 2YKB; X-ray; 1.93 A; A=18-223.
DR   PDB; 2YKC; X-ray; 1.67 A; A=18-223.
DR   PDB; 2YKE; X-ray; 1.43 A; A=18-223.
DR   PDB; 2YKI; X-ray; 1.67 A; A=18-223.
DR   PDB; 2YKJ; X-ray; 1.46 A; A=18-223.
DR   PDB; 3B24; X-ray; 1.70 A; A/B=9-236.
DR   PDB; 3B25; X-ray; 1.75 A; A=9-236.
DR   PDB; 3B26; X-ray; 2.10 A; A/B=9-236.
DR   PDB; 3B27; X-ray; 1.50 A; A=9-236.
DR   PDB; 3B28; X-ray; 1.35 A; A/B=9-236.
DR   PDB; 3BM9; X-ray; 1.60 A; A=14-236.
DR   PDB; 3BMY; X-ray; 1.60 A; A=14-236.
DR   PDB; 3D0B; X-ray; 1.74 A; A=1-232.
DR   PDB; 3EKO; X-ray; 1.55 A; A/B=9-225.
DR   PDB; 3EKR; X-ray; 2.00 A; A/B=9-225.
DR   PDB; 3FT5; X-ray; 1.90 A; A=9-236.
DR   PDB; 3FT8; X-ray; 2.00 A; A=9-236.
DR   PDB; 3HEK; X-ray; 1.95 A; A/B=9-225.
DR   PDB; 3HHU; X-ray; 1.59 A; A/B=1-224.
DR   PDB; 3HYY; X-ray; 1.90 A; A=9-236.
DR   PDB; 3HYZ; X-ray; 2.30 A; A/B=9-236.
DR   PDB; 3HZ1; X-ray; 2.30 A; A=9-236.
DR   PDB; 3HZ5; X-ray; 1.90 A; A=9-236.
DR   PDB; 3INW; X-ray; 1.95 A; A=10-236.
DR   PDB; 3INX; X-ray; 1.75 A; A=10-236.
DR   PDB; 3K97; X-ray; 1.95 A; A=9-236.
DR   PDB; 3K98; X-ray; 2.40 A; A/B=9-225.
DR   PDB; 3K99; X-ray; 2.10 A; A/B/C/D=9-225.
DR   PDB; 3MNR; X-ray; 1.90 A; P=1-232.
DR   PDB; 3O0I; X-ray; 1.47 A; A=1-236.
DR   PDB; 3OW6; X-ray; 1.80 A; A=17-223.
DR   PDB; 3OWB; X-ray; 2.05 A; A=17-223.
DR   PDB; 3OWD; X-ray; 1.63 A; A=17-223.
DR   PDB; 3Q6M; X-ray; 3.00 A; A/B/C=293-732.
DR   PDB; 3Q6N; X-ray; 3.05 A; A/B/C/D/E/F=293-732.
DR   PDB; 3QDD; X-ray; 1.79 A; A=1-236.
DR   PDB; 3QTF; X-ray; 1.57 A; A=14-236.
DR   PDB; 3R4M; X-ray; 1.70 A; A=9-236.
DR   PDB; 3R4N; X-ray; 2.00 A; A/B=9-225.
DR   PDB; 3R4O; X-ray; 2.65 A; A/B=9-225.
DR   PDB; 3R4P; X-ray; 1.70 A; A/B=9-225.
DR   PDB; 3R91; X-ray; 1.58 A; A=14-236.
DR   PDB; 3R92; X-ray; 1.58 A; A=14-236.
DR   PDB; 3RKZ; X-ray; 1.57 A; A=14-236.
DR   PDB; 3RLP; X-ray; 1.70 A; A/B=9-225.
DR   PDB; 3RLQ; X-ray; 1.90 A; A/B=9-225.
DR   PDB; 3RLR; X-ray; 1.70 A; A/B=9-225.
DR   PDB; 3T0H; X-ray; 1.20 A; A=9-236.
DR   PDB; 3T0Z; X-ray; 2.19 A; A=9-236.
DR   PDB; 3T10; X-ray; 1.24 A; A=9-236.
DR   PDB; 3T1K; X-ray; 1.50 A; A/B=9-236.
DR   PDB; 3T2S; X-ray; 1.50 A; A/B=9-236.
DR   PDB; 3TUH; X-ray; 1.80 A; A/B=16-224.
DR   PDB; 3VHA; X-ray; 1.39 A; A=9-236.
DR   PDB; 3VHC; X-ray; 1.41 A; A=9-236.
DR   PDB; 3VHD; X-ray; 1.52 A; A/B=9-236.
DR   PDB; 3WHA; X-ray; 1.30 A; A/B=9-236.
DR   PDB; 3WQ9; X-ray; 1.80 A; A=1-236.
DR   PDB; 4AIF; X-ray; 2.01 A; D/E=726-732.
DR   PDB; 4AWO; X-ray; 1.70 A; A/B=9-236.
DR   PDB; 4AWP; X-ray; 1.82 A; A/B=9-236.
DR   PDB; 4AWQ; X-ray; 1.60 A; A/B=9-236.
DR   PDB; 4B7P; X-ray; 1.70 A; A=9-236.
DR   PDB; 4BQG; X-ray; 1.90 A; A=9-236.
DR   PDB; 4BQJ; X-ray; 2.00 A; A=9-236.
DR   PDB; 4CGQ; X-ray; 2.00 A; Q=726-732.
DR   PDB; 4CGU; X-ray; 2.11 A; C=726-732.
DR   PDB; 4CGV; X-ray; 2.54 A; E/F=726-732.
DR   PDB; 4CGW; X-ray; 3.00 A; C/D=726-732.
DR   PDB; 4CWF; X-ray; 2.00 A; A=9-236.
DR   PDB; 4CWN; X-ray; 1.80 A; A=9-236.
DR   PDB; 4CWO; X-ray; 2.31 A; A=9-236.
DR   PDB; 4CWP; X-ray; 1.95 A; A=9-236.
DR   PDB; 4CWQ; X-ray; 2.00 A; A=9-236.
DR   PDB; 4CWR; X-ray; 2.00 A; A=9-236.
DR   PDB; 4CWS; X-ray; 2.30 A; A=9-236.
DR   PDB; 4CWT; X-ray; 1.90 A; A=9-236.
DR   PDB; 4EEH; X-ray; 1.60 A; A=9-236.
DR   PDB; 4EFT; X-ray; 2.12 A; A=9-236.
DR   PDB; 4EFU; X-ray; 2.00 A; A=9-236.
DR   PDB; 4EGH; X-ray; 1.60 A; A=9-236.
DR   PDB; 4EGI; X-ray; 1.79 A; A=9-236.
DR   PDB; 4EGK; X-ray; 1.69 A; A=9-236.
DR   PDB; 4FCP; X-ray; 2.00 A; A/B=1-236.
DR   PDB; 4FCQ; X-ray; 2.15 A; A=1-236.
DR   PDB; 4FCR; X-ray; 1.70 A; A=1-236.
DR   PDB; 4HY6; X-ray; 1.65 A; A=9-236.
DR   PDB; 4JQL; X-ray; 1.72 A; A=9-236.
DR   PDB; 4L8Z; X-ray; 1.70 A; A=9-236.
DR   PDB; 4L90; X-ray; 2.00 A; A=9-236.
DR   PDB; 4L91; X-ray; 1.75 A; A=9-236.
DR   PDB; 4L93; X-ray; 1.84 A; A/B=9-236.
DR   PDB; 4L94; X-ray; 1.65 A; A=9-236.
DR   PDB; 4LWE; X-ray; 1.50 A; A=17-224.
DR   PDB; 4LWF; X-ray; 1.75 A; A=17-224.
DR   PDB; 4LWG; X-ray; 1.60 A; A=17-224.
DR   PDB; 4LWH; X-ray; 1.70 A; A=16-224.
DR   PDB; 4LWI; X-ray; 1.70 A; A=17-224.
DR   PDB; 4NH7; X-ray; 2.00 A; A/B=9-236.
DR   PDB; 4NH8; X-ray; 1.65 A; A=9-236.
DR   PDB; 4O04; X-ray; 1.82 A; A=9-236.
DR   PDB; 4O05; X-ray; 1.79 A; A=9-236.
DR   PDB; 4O07; X-ray; 1.86 A; A=9-236.
DR   PDB; 4O09; X-ray; 1.96 A; A=9-236.
DR   PDB; 4O0B; X-ray; 1.93 A; A=9-236.
DR   PDB; 4R3M; X-ray; 1.80 A; A=16-224.
DR   PDB; 4U93; X-ray; 1.55 A; A=1-236.
DR   PDB; 4W7T; X-ray; 1.80 A; A=1-236.
DR   PDB; 4XIP; X-ray; 1.70 A; A=9-236.
DR   PDB; 4XIQ; X-ray; 1.84 A; A=9-236.
DR   PDB; 4XIR; X-ray; 1.70 A; A=9-236.
DR   PDB; 4XIT; X-ray; 1.86 A; A=9-236.
DR   PDB; 4YKQ; X-ray; 1.91 A; A=2-236.
DR   PDB; 4YKR; X-ray; 1.61 A; A=2-236.
DR   PDB; 4YKT; X-ray; 1.85 A; A=2-236.
DR   PDB; 4YKU; X-ray; 1.70 A; A=2-236.
DR   PDB; 4YKW; X-ray; 1.85 A; A/B=2-236.
DR   PDB; 4YKX; X-ray; 1.80 A; A=2-236.
DR   PDB; 4YKY; X-ray; 1.78 A; A=2-236.
DR   PDB; 4YKZ; X-ray; 1.85 A; A=2-236.
DR   PDB; 5CF0; X-ray; 1.80 A; A=9-236.
DR   PDB; 5FNC; X-ray; 2.20 A; A=1-236.
DR   PDB; 5FND; X-ray; 2.00 A; A=1-236.
DR   PDB; 5FNF; X-ray; 2.10 A; A=1-236.
DR   PDB; 5GGZ; X-ray; 2.02 A; A/B/C/D=16-225.
DR   PDB; 5J20; X-ray; 1.76 A; A=17-223.
DR   PDB; 5J27; X-ray; 1.70 A; A=16-224.
DR   PDB; 5J2V; X-ray; 1.59 A; A=17-223.
DR   PDB; 5J2X; X-ray; 1.22 A; A=17-224.
DR   PDB; 5J64; X-ray; 1.38 A; A=9-236.
DR   PDB; 5J6L; X-ray; 1.75 A; A=9-236.
DR   PDB; 5J6M; X-ray; 1.64 A; A=9-234.
DR   PDB; 5J6N; X-ray; 1.90 A; A=9-234.
DR   PDB; 5J80; X-ray; 1.17 A; A=9-233.
DR   PDB; 5J82; X-ray; 2.17 A; A=9-233.
DR   PDB; 5J86; X-ray; 1.87 A; A=9-233.
DR   PDB; 5J8M; X-ray; 1.90 A; A/B=9-233.
DR   PDB; 5J8U; X-ray; 1.75 A; A/B=9-233.
DR   PDB; 5J9X; X-ray; 1.80 A; A=9-233.
DR   PDB; 5LNY; X-ray; 1.88 A; A=9-236.
DR   PDB; 5LNZ; X-ray; 1.54 A; A=9-236.
DR   PDB; 5LO0; X-ray; 2.30 A; A=9-236.
DR   PDB; 5LO1; X-ray; 2.70 A; A=9-236.
DR   PDB; 5LO5; X-ray; 1.44 A; A=9-236.
DR   PDB; 5LO6; X-ray; 2.40 A; A=9-236.
DR   PDB; 5LQ9; X-ray; 1.90 A; A=17-223.
DR   PDB; 5LR1; X-ray; 1.44 A; A=18-223.
DR   PDB; 5LR7; X-ray; 1.86 A; A=18-223.
DR   PDB; 5LRL; X-ray; 1.33 A; A=18-223.
DR   PDB; 5LRZ; X-ray; 2.00 A; A=18-223.
DR   PDB; 5LS1; X-ray; 1.85 A; A=17-223.
DR   PDB; 5M4E; X-ray; 1.90 A; A=9-236.
DR   PDB; 5M4H; X-ray; 2.00 A; A=9-236.
DR   PDB; 5NYH; X-ray; 1.65 A; A=9-236.
DR   PDB; 5NYI; X-ray; 1.44 A; A=9-235.
DR   PDB; 5OCI; X-ray; 1.62 A; A=9-236.
DR   PDB; 5OD7; X-ray; 2.00 A; A=9-236.
DR   PDB; 5ODX; X-ray; 1.82 A; A=9-236.
DR   PDB; 5T21; X-ray; 2.10 A; A=18-223.
DR   PDB; 5VYY; X-ray; 1.79 A; A=1-236.
DR   PDB; 5XQD; X-ray; 1.60 A; A=9-236.
DR   PDB; 5XQE; X-ray; 1.70 A; A=9-236.
DR   PDB; 5XR5; X-ray; 1.60 A; A=9-236.
DR   PDB; 5XR9; X-ray; 1.50 A; A=9-236.
DR   PDB; 5XRB; X-ray; 1.65 A; A=9-236.
DR   PDB; 5XRD; X-ray; 1.30 A; A=9-236.
DR   PDB; 5XRE; X-ray; 1.50 A; A=9-236.
DR   PDB; 5ZR3; X-ray; 2.50 A; A/C/E/G=1-236.
DR   PDB; 6B99; X-ray; 1.60 A; A=1-236.
DR   PDB; 6B9A; X-ray; 1.65 A; A/B=1-236.
DR   PDB; 6CEO; X-ray; 1.90 A; A=1-236.
DR   PDB; 6CYG; X-ray; 1.50 A; A/B=1-236.
DR   PDB; 6CYH; X-ray; 1.49 A; A/B=1-236.
DR   PDB; 6EI5; X-ray; 2.20 A; A=15-223.
DR   PDB; 6EL5; X-ray; 1.67 A; A=1-236.
DR   PDB; 6ELN; X-ray; 1.60 A; A=17-223.
DR   PDB; 6ELO; X-ray; 1.80 A; A=1-236.
DR   PDB; 6ELP; X-ray; 1.85 A; A=1-236.
DR   PDB; 6EY8; X-ray; 2.16 A; A=1-236.
DR   PDB; 6EY9; X-ray; 2.00 A; A=1-236.
DR   PDB; 6EYA; X-ray; 2.10 A; A=1-236.
DR   PDB; 6EYB; X-ray; 1.90 A; A=1-236.
DR   PDB; 6F1N; X-ray; 2.09 A; A=1-236.
DR   PDB; 6FCJ; X-ray; 2.49 A; A=9-236.
DR   PDB; 6FDP; NMR; -; B=724-732.
DR   PDB; 6GP4; X-ray; 1.70 A; A=1-236.
DR   PDB; 6GP8; X-ray; 1.75 A; A=1-236.
DR   PDB; 6GPF; X-ray; 1.55 A; A=1-236.
DR   PDB; 6GPH; X-ray; 1.56 A; A=1-236.
DR   PDB; 6GPO; X-ray; 1.48 A; A=1-236.
DR   PDB; 6GPP; X-ray; 1.51 A; A=1-236.
DR   PDB; 6GPR; X-ray; 2.35 A; A=1-236.
DR   PDB; 6GPT; X-ray; 2.00 A; A=1-236.
DR   PDB; 6GPW; X-ray; 1.60 A; A=1-236.
DR   PDB; 6GPY; X-ray; 2.25 A; A=1-236.
DR   PDB; 6GQ6; X-ray; 2.25 A; A=1-236.
DR   PDB; 6GQR; X-ray; 2.05 A; A=1-236.
DR   PDB; 6GQS; X-ray; 1.43 A; A=1-236.
DR   PDB; 6GQU; X-ray; 1.72 A; A=1-236.
DR   PDB; 6GR1; X-ray; 2.05 A; A=1-236.
DR   PDB; 6GR3; X-ray; 1.88 A; A=1-236.
DR   PDB; 6GR4; X-ray; 1.50 A; A=1-236.
DR   PDB; 6GR5; X-ray; 1.34 A; A=1-236.
DR   PDB; 6HHR; X-ray; 2.00 A; A=17-224.
DR   PDB; 6KSQ; X-ray; 2.20 A; A=293-554.
DR   PDB; 6LR9; X-ray; 2.20 A; A=9-236.
DR   PDB; 6LSZ; X-ray; 1.99 A; A=9-236.
DR   PDB; 6LT8; X-ray; 1.59 A; A=9-236.
DR   PDB; 6LTI; X-ray; 1.59 A; A=9-236.
DR   PDB; 6LTK; X-ray; 2.14 A; A=9-236.
DR   PDB; 6N8X; X-ray; 1.49 A; A=1-236.
DR   PDB; 6OLX; X-ray; 1.44 A; A=1-236.
DR   PDB; 6TN4; X-ray; 1.27 A; AAA=9-236.
DR   PDB; 6TN5; X-ray; 1.17 A; AAA=9-236.
DR   PDB; 6U98; X-ray; 1.50 A; A=2-236.
DR   PDB; 6U99; X-ray; 1.60 A; A=2-236.
DR   PDB; 6U9A; X-ray; 1.65 A; A=2-236.
DR   PDB; 6U9B; X-ray; 1.75 A; A=2-236.
DR   PDB; 7DMC; X-ray; 2.34 A; A=16-224.
DR   PDB; 7H9K; X-ray; 1.66 A; A=8-236.
DR   PDB; 7H9L; X-ray; 1.42 A; A=8-236.
DR   PDB; 7H9M; X-ray; 1.49 A; A=8-236.
DR   PDB; 7H9N; X-ray; 2.35 A; A=8-236.
DR   PDB; 7H9O; X-ray; 1.55 A; A=8-236.
DR   PDB; 7H9P; X-ray; 1.64 A; A=8-236.
DR   PDB; 7H9Q; X-ray; 1.51 A; A=8-236.
DR   PDB; 7H9R; X-ray; 1.69 A; A=8-236.
DR   PDB; 7H9S; X-ray; 2.17 A; A=8-236.
DR   PDB; 7H9T; X-ray; 2.48 A; A=8-236.
DR   PDB; 7H9U; X-ray; 1.94 A; A=8-236.
DR   PDB; 7H9V; X-ray; 1.52 A; A=8-236.
DR   PDB; 7H9W; X-ray; 1.64 A; A=8-236.
DR   PDB; 7H9X; X-ray; 1.47 A; A=8-236.
DR   PDB; 7H9Y; X-ray; 2.11 A; A=8-236.
DR   PDB; 7H9Z; X-ray; 2.06 A; A=8-236.
DR   PDB; 7HA0; X-ray; 1.47 A; A=8-236.
DR   PDB; 7HA1; X-ray; 1.46 A; A=8-236.
DR   PDB; 7HA2; X-ray; 1.73 A; A=8-236.
DR   PDB; 7HA3; X-ray; 1.98 A; A=8-236.
DR   PDB; 7HA4; X-ray; 1.61 A; A=8-236.
DR   PDB; 7HA5; X-ray; 1.53 A; A=8-236.
DR   PDB; 7HA6; X-ray; 1.80 A; A=8-236.
DR   PDB; 7HA7; X-ray; 2.27 A; A=8-236.
DR   PDB; 7HA8; X-ray; 2.22 A; A=8-236.
DR   PDB; 7HA9; X-ray; 2.00 A; A=8-236.
DR   PDB; 7HAA; X-ray; 1.67 A; A=8-236.
DR   PDB; 7HAB; X-ray; 1.50 A; A=8-236.
DR   PDB; 7HAC; X-ray; 1.68 A; A=8-236.
DR   PDB; 7HAD; X-ray; 1.59 A; A=8-236.
DR   PDB; 7HAE; X-ray; 1.73 A; A=8-236.
DR   PDB; 7HAF; X-ray; 1.61 A; A=8-236.
DR   PDB; 7HAG; X-ray; 1.53 A; A=8-236.
DR   PDB; 7HAH; X-ray; 1.60 A; A=8-236.
DR   PDB; 7HAI; X-ray; 1.65 A; A=8-236.
DR   PDB; 7HAJ; X-ray; 1.57 A; A=8-236.
DR   PDB; 7HAK; X-ray; 1.72 A; A=8-236.
DR   PDB; 7HAL; X-ray; 1.65 A; A=8-236.
DR   PDB; 7HAM; X-ray; 1.77 A; A=8-236.
DR   PDB; 7HAN; X-ray; 1.61 A; A=8-236.
DR   PDB; 7HAO; X-ray; 1.83 A; A=8-236.
DR   PDB; 7HAP; X-ray; 2.35 A; A=8-236.
DR   PDB; 7HAQ; X-ray; 1.55 A; A=8-236.
DR   PDB; 7HAR; X-ray; 1.77 A; A=8-236.
DR   PDB; 7HAS; X-ray; 2.08 A; A=8-236.
DR   PDB; 7HAT; X-ray; 2.04 A; A=8-236.
DR   PDB; 7HAU; X-ray; 1.75 A; A=8-236.
DR   PDB; 7HAV; X-ray; 2.45 A; A=8-236.
DR   PDB; 7HAW; X-ray; 1.65 A; A=8-236.
DR   PDB; 7HAX; X-ray; 2.29 A; A=8-236.
DR   PDB; 7HAY; X-ray; 2.27 A; A=8-236.
DR   PDB; 7HAZ; X-ray; 1.68 A; A=8-236.
DR   PDB; 7HB0; X-ray; 1.78 A; A=8-236.
DR   PDB; 7HB1; X-ray; 1.66 A; A=8-236.
DR   PDB; 7HB2; X-ray; 1.67 A; A=8-236.
DR   PDB; 7HB3; X-ray; 2.34 A; A=8-236.
DR   PDB; 7HB4; X-ray; 1.87 A; A=8-236.
DR   PDB; 7HB5; X-ray; 1.80 A; A=8-236.
DR   PDB; 7HB6; X-ray; 2.09 A; A=8-236.
DR   PDB; 7HB7; X-ray; 2.98 A; A=8-236.
DR   PDB; 7HB8; X-ray; 1.85 A; A=8-236.
DR   PDB; 7HB9; X-ray; 1.89 A; A=8-236.
DR   PDB; 7HBA; X-ray; 2.15 A; A=8-236.
DR   PDB; 7HBB; X-ray; 1.84 A; A=8-236.
DR   PDB; 7HBC; X-ray; 1.86 A; A=8-236.
DR   PDB; 7HBD; X-ray; 1.80 A; A=8-236.
DR   PDB; 7HBE; X-ray; 1.79 A; A=8-236.
DR   PDB; 7HBF; X-ray; 1.97 A; A=8-236.
DR   PDB; 7HBG; X-ray; 1.69 A; A=8-236.
DR   PDB; 7HBH; X-ray; 1.80 A; A=8-236.
DR   PDB; 7HBJ; X-ray; 2.65 A; A=8-236.
DR   PDB; 7HBK; X-ray; 2.14 A; A=8-236.
DR   PDB; 7HBL; X-ray; 1.65 A; A=8-236.
DR   PDB; 7HBM; X-ray; 2.21 A; A=8-236.
DR   PDB; 7HBN; X-ray; 1.99 A; A=8-236.
DR   PDB; 7HBO; X-ray; 2.07 A; A=8-236.
DR   PDB; 7HBP; X-ray; 1.91 A; A=8-236.
DR   PDB; 7HBQ; X-ray; 2.73 A; A=8-236.
DR   PDB; 7HBR; X-ray; 1.91 A; A=8-236.
DR   PDB; 7HBS; X-ray; 1.38 A; A=8-236.
DR   PDB; 7HBT; X-ray; 1.38 A; A=8-236.
DR   PDB; 7HBU; X-ray; 1.44 A; A=8-236.
DR   PDB; 7HBV; X-ray; 1.56 A; A=8-236.
DR   PDB; 7HBW; X-ray; 1.91 A; A=8-236.
DR   PDB; 7HBX; X-ray; 2.25 A; A=8-236.
DR   PDB; 7HBY; X-ray; 1.82 A; A=8-236.
DR   PDB; 7HBZ; X-ray; 1.44 A; A=8-236.
DR   PDB; 7HC0; X-ray; 1.66 A; A=8-236.
DR   PDB; 7HC1; X-ray; 2.13 A; A=8-236.
DR   PDB; 7HC2; X-ray; 1.60 A; A=8-236.
DR   PDB; 7HC3; X-ray; 2.22 A; A=8-236.
DR   PDB; 7KRJ; EM; 2.56 A; A/B=1-732.
DR   PDB; 7KW7; EM; 3.57 A; A/B=1-732.
DR   PDB; 7L7I; EM; 3.30 A; A/B=1-732.
DR   PDB; 7L7J; EM; 3.10 A; A/B=1-732.
DR   PDB; 7LSZ; X-ray; 1.70 A; A=1-293.
DR   PDB; 7LT0; X-ray; 1.70 A; A=1-293.
DR   PDB; 7RXZ; X-ray; 3.15 A; A/B/C/D/E/F=293-714.
DR   PDB; 7RY0; X-ray; 2.20 A; A/B=293-714.
DR   PDB; 7RY1; X-ray; 3.52 A; A/B/C=293-714.
DR   PDB; 7S8Y; X-ray; 1.59 A; A=1-236.
DR   PDB; 7S8Z; X-ray; 1.64 A; A=1-236.
DR   PDB; 7S90; X-ray; 1.79 A; A=1-236.
DR   PDB; 7S95; X-ray; 1.71 A; A=1-236.
DR   PDB; 7S98; X-ray; 1.90 A; A=1-236.
DR   PDB; 7S99; X-ray; 1.52 A; A=1-236.
DR   PDB; 7S9F; X-ray; 2.30 A; A=1-236.
DR   PDB; 7S9G; X-ray; 1.79 A; A=1-236.
DR   PDB; 7S9H; X-ray; 1.45 A; A=1-236.
DR   PDB; 7S9I; X-ray; 1.75 A; A=1-236.
DR   PDB; 7UR3; X-ray; 1.60 A; A=1-293.
DR   PDB; 8AGI; X-ray; 2.10 A; A/B=1-236.
DR   PDB; 8AGJ; X-ray; 2.32 A; A/B=1-236.
DR   PDB; 8AGL; X-ray; 2.20 A; A/B=1-236.
DR   PDB; 8B7I; NMR; -; A=9-236.
DR   PDB; 8B7J; NMR; -; A=9-236.
DR   PDB; 8FFV; EM; 3.01 A; A/B=2-732.
DR   PDB; 8FFW; EM; 3.23 A; A/B=2-732.
DR   PDB; 8JR6; NMR; -; A=1-237.
DR   PDB; 8JR7; NMR; -; A=1-237.
DR   PDB; 8JRA; NMR; -; A=1-237.
DR   PDB; 8KI4; X-ray; 1.55 A; A/B=9-236.
DR   PDB; 8SBT; X-ray; 1.50 A; A=1-236.
DR   PDB; 8W4V; X-ray; 1.81 A; A=9-236.
DR   PDB; 8W8K; X-ray; 2.25 A; A/B=9-236.
DR   PDB; 8X2R; X-ray; 1.45 A; A=1-236.
DR   PDB; 9AUU; X-ray; 2.00 A; A=2-236.
DR   PDBsum; 1BYQ; -.
DR   PDBsum; 1OSF; -.
DR   PDBsum; 1UY6; -.
DR   PDBsum; 1UY7; -.
DR   PDBsum; 1UY8; -.
DR   PDBsum; 1UY9; -.
DR   PDBsum; 1UYC; -.
DR   PDBsum; 1UYD; -.
DR   PDBsum; 1UYE; -.
DR   PDBsum; 1UYF; -.
DR   PDBsum; 1UYG; -.
DR   PDBsum; 1UYH; -.
DR   PDBsum; 1UYI; -.
DR   PDBsum; 1UYK; -.
DR   PDBsum; 1UYL; -.
DR   PDBsum; 1YC1; -.
DR   PDBsum; 1YC3; -.
DR   PDBsum; 1YC4; -.
DR   PDBsum; 1YER; -.
DR   PDBsum; 1YES; -.
DR   PDBsum; 1YET; -.
DR   PDBsum; 2BSM; -.
DR   PDBsum; 2BT0; -.
DR   PDBsum; 2BUG; -.
DR   PDBsum; 2BYH; -.
DR   PDBsum; 2BYI; -.
DR   PDBsum; 2BZ5; -.
DR   PDBsum; 2C2L; -.
DR   PDBsum; 2CCS; -.
DR   PDBsum; 2CCT; -.
DR   PDBsum; 2CCU; -.
DR   PDBsum; 2FWY; -.
DR   PDBsum; 2FWZ; -.
DR   PDBsum; 2H55; -.
DR   PDBsum; 2JJC; -.
DR   PDBsum; 2K5B; -.
DR   PDBsum; 2QF6; -.
DR   PDBsum; 2QFO; -.
DR   PDBsum; 2QG0; -.
DR   PDBsum; 2QG2; -.
DR   PDBsum; 2UWD; -.
DR   PDBsum; 2VCI; -.
DR   PDBsum; 2VCJ; -.
DR   PDBsum; 2WI1; -.
DR   PDBsum; 2WI2; -.
DR   PDBsum; 2WI3; -.
DR   PDBsum; 2WI4; -.
DR   PDBsum; 2WI5; -.
DR   PDBsum; 2WI6; -.
DR   PDBsum; 2WI7; -.
DR   PDBsum; 2XAB; -.
DR   PDBsum; 2XDK; -.
DR   PDBsum; 2XDL; -.
DR   PDBsum; 2XDS; -.
DR   PDBsum; 2XDU; -.
DR   PDBsum; 2XDX; -.
DR   PDBsum; 2XHR; -.
DR   PDBsum; 2XHT; -.
DR   PDBsum; 2XHX; -.
DR   PDBsum; 2XJG; -.
DR   PDBsum; 2XJJ; -.
DR   PDBsum; 2XJX; -.
DR   PDBsum; 2XK2; -.
DR   PDBsum; 2YE2; -.
DR   PDBsum; 2YE3; -.
DR   PDBsum; 2YE4; -.
DR   PDBsum; 2YE5; -.
DR   PDBsum; 2YE6; -.
DR   PDBsum; 2YE7; -.
DR   PDBsum; 2YE8; -.
DR   PDBsum; 2YE9; -.
DR   PDBsum; 2YEA; -.
DR   PDBsum; 2YEB; -.
DR   PDBsum; 2YEC; -.
DR   PDBsum; 2YED; -.
DR   PDBsum; 2YEE; -.
DR   PDBsum; 2YEF; -.
DR   PDBsum; 2YEG; -.
DR   PDBsum; 2YEH; -.
DR   PDBsum; 2YEI; -.
DR   PDBsum; 2YEJ; -.
DR   PDBsum; 2YI0; -.
DR   PDBsum; 2YI5; -.
DR   PDBsum; 2YI6; -.
DR   PDBsum; 2YI7; -.
DR   PDBsum; 2YJW; -.
DR   PDBsum; 2YJX; -.
DR   PDBsum; 2YK2; -.
DR   PDBsum; 2YK9; -.
DR   PDBsum; 2YKB; -.
DR   PDBsum; 2YKC; -.
DR   PDBsum; 2YKE; -.
DR   PDBsum; 2YKI; -.
DR   PDBsum; 2YKJ; -.
DR   PDBsum; 3B24; -.
DR   PDBsum; 3B25; -.
DR   PDBsum; 3B26; -.
DR   PDBsum; 3B27; -.
DR   PDBsum; 3B28; -.
DR   PDBsum; 3BM9; -.
DR   PDBsum; 3BMY; -.
DR   PDBsum; 3D0B; -.
DR   PDBsum; 3EKO; -.
DR   PDBsum; 3EKR; -.
DR   PDBsum; 3FT5; -.
DR   PDBsum; 3FT8; -.
DR   PDBsum; 3HEK; -.
DR   PDBsum; 3HHU; -.
DR   PDBsum; 3HYY; -.
DR   PDBsum; 3HYZ; -.
DR   PDBsum; 3HZ1; -.
DR   PDBsum; 3HZ5; -.
DR   PDBsum; 3INW; -.
DR   PDBsum; 3INX; -.
DR   PDBsum; 3K97; -.
DR   PDBsum; 3K98; -.
DR   PDBsum; 3K99; -.
DR   PDBsum; 3MNR; -.
DR   PDBsum; 3O0I; -.
DR   PDBsum; 3OW6; -.
DR   PDBsum; 3OWB; -.
DR   PDBsum; 3OWD; -.
DR   PDBsum; 3Q6M; -.
DR   PDBsum; 3Q6N; -.
DR   PDBsum; 3QDD; -.
DR   PDBsum; 3QTF; -.
DR   PDBsum; 3R4M; -.
DR   PDBsum; 3R4N; -.
DR   PDBsum; 3R4O; -.
DR   PDBsum; 3R4P; -.
DR   PDBsum; 3R91; -.
DR   PDBsum; 3R92; -.
DR   PDBsum; 3RKZ; -.
DR   PDBsum; 3RLP; -.
DR   PDBsum; 3RLQ; -.
DR   PDBsum; 3RLR; -.
DR   PDBsum; 3T0H; -.
DR   PDBsum; 3T0Z; -.
DR   PDBsum; 3T10; -.
DR   PDBsum; 3T1K; -.
DR   PDBsum; 3T2S; -.
DR   PDBsum; 3TUH; -.
DR   PDBsum; 3VHA; -.
DR   PDBsum; 3VHC; -.
DR   PDBsum; 3VHD; -.
DR   PDBsum; 3WHA; -.
DR   PDBsum; 3WQ9; -.
DR   PDBsum; 4AIF; -.
DR   PDBsum; 4AWO; -.
DR   PDBsum; 4AWP; -.
DR   PDBsum; 4AWQ; -.
DR   PDBsum; 4B7P; -.
DR   PDBsum; 4BQG; -.
DR   PDBsum; 4BQJ; -.
DR   PDBsum; 4CGQ; -.
DR   PDBsum; 4CGU; -.
DR   PDBsum; 4CGV; -.
DR   PDBsum; 4CGW; -.
DR   PDBsum; 4CWF; -.
DR   PDBsum; 4CWN; -.
DR   PDBsum; 4CWO; -.
DR   PDBsum; 4CWP; -.
DR   PDBsum; 4CWQ; -.
DR   PDBsum; 4CWR; -.
DR   PDBsum; 4CWS; -.
DR   PDBsum; 4CWT; -.
DR   PDBsum; 4EEH; -.
DR   PDBsum; 4EFT; -.
DR   PDBsum; 4EFU; -.
DR   PDBsum; 4EGH; -.
DR   PDBsum; 4EGI; -.
DR   PDBsum; 4EGK; -.
DR   PDBsum; 4FCP; -.
DR   PDBsum; 4FCQ; -.
DR   PDBsum; 4FCR; -.
DR   PDBsum; 4HY6; -.
DR   PDBsum; 4JQL; -.
DR   PDBsum; 4L8Z; -.
DR   PDBsum; 4L90; -.
DR   PDBsum; 4L91; -.
DR   PDBsum; 4L93; -.
DR   PDBsum; 4L94; -.
DR   PDBsum; 4LWE; -.
DR   PDBsum; 4LWF; -.
DR   PDBsum; 4LWG; -.
DR   PDBsum; 4LWH; -.
DR   PDBsum; 4LWI; -.
DR   PDBsum; 4NH7; -.
DR   PDBsum; 4NH8; -.
DR   PDBsum; 4O04; -.
DR   PDBsum; 4O05; -.
DR   PDBsum; 4O07; -.
DR   PDBsum; 4O09; -.
DR   PDBsum; 4O0B; -.
DR   PDBsum; 4R3M; -.
DR   PDBsum; 4U93; -.
DR   PDBsum; 4W7T; -.
DR   PDBsum; 4XIP; -.
DR   PDBsum; 4XIQ; -.
DR   PDBsum; 4XIR; -.
DR   PDBsum; 4XIT; -.
DR   PDBsum; 4YKQ; -.
DR   PDBsum; 4YKR; -.
DR   PDBsum; 4YKT; -.
DR   PDBsum; 4YKU; -.
DR   PDBsum; 4YKW; -.
DR   PDBsum; 4YKX; -.
DR   PDBsum; 4YKY; -.
DR   PDBsum; 4YKZ; -.
DR   PDBsum; 5CF0; -.
DR   PDBsum; 5FNC; -.
DR   PDBsum; 5FND; -.
DR   PDBsum; 5FNF; -.
DR   PDBsum; 5GGZ; -.
DR   PDBsum; 5J20; -.
DR   PDBsum; 5J27; -.
DR   PDBsum; 5J2V; -.
DR   PDBsum; 5J2X; -.
DR   PDBsum; 5J64; -.
DR   PDBsum; 5J6L; -.
DR   PDBsum; 5J6M; -.
DR   PDBsum; 5J6N; -.
DR   PDBsum; 5J80; -.
DR   PDBsum; 5J82; -.
DR   PDBsum; 5J86; -.
DR   PDBsum; 5J8M; -.
DR   PDBsum; 5J8U; -.
DR   PDBsum; 5J9X; -.
DR   PDBsum; 5LNY; -.
DR   PDBsum; 5LNZ; -.
DR   PDBsum; 5LO0; -.
DR   PDBsum; 5LO1; -.
DR   PDBsum; 5LO5; -.
DR   PDBsum; 5LO6; -.
DR   PDBsum; 5LQ9; -.
DR   PDBsum; 5LR1; -.
DR   PDBsum; 5LR7; -.
DR   PDBsum; 5LRL; -.
DR   PDBsum; 5LRZ; -.
DR   PDBsum; 5LS1; -.
DR   PDBsum; 5M4E; -.
DR   PDBsum; 5M4H; -.
DR   PDBsum; 5NYH; -.
DR   PDBsum; 5NYI; -.
DR   PDBsum; 5OCI; -.
DR   PDBsum; 5OD7; -.
DR   PDBsum; 5ODX; -.
DR   PDBsum; 5T21; -.
DR   PDBsum; 5VYY; -.
DR   PDBsum; 5XQD; -.
DR   PDBsum; 5XQE; -.
DR   PDBsum; 5XR5; -.
DR   PDBsum; 5XR9; -.
DR   PDBsum; 5XRB; -.
DR   PDBsum; 5XRD; -.
DR   PDBsum; 5XRE; -.
DR   PDBsum; 5ZR3; -.
DR   PDBsum; 6B99; -.
DR   PDBsum; 6B9A; -.
DR   PDBsum; 6CEO; -.
DR   PDBsum; 6CYG; -.
DR   PDBsum; 6CYH; -.
DR   PDBsum; 6EI5; -.
DR   PDBsum; 6EL5; -.
DR   PDBsum; 6ELN; -.
DR   PDBsum; 6ELO; -.
DR   PDBsum; 6ELP; -.
DR   PDBsum; 6EY8; -.
DR   PDBsum; 6EY9; -.
DR   PDBsum; 6EYA; -.
DR   PDBsum; 6EYB; -.
DR   PDBsum; 6F1N; -.
DR   PDBsum; 6FCJ; -.
DR   PDBsum; 6FDP; -.
DR   PDBsum; 6GP4; -.
DR   PDBsum; 6GP8; -.
DR   PDBsum; 6GPF; -.
DR   PDBsum; 6GPH; -.
DR   PDBsum; 6GPO; -.
DR   PDBsum; 6GPP; -.
DR   PDBsum; 6GPR; -.
DR   PDBsum; 6GPT; -.
DR   PDBsum; 6GPW; -.
DR   PDBsum; 6GPY; -.
DR   PDBsum; 6GQ6; -.
DR   PDBsum; 6GQR; -.
DR   PDBsum; 6GQS; -.
DR   PDBsum; 6GQU; -.
DR   PDBsum; 6GR1; -.
DR   PDBsum; 6GR3; -.
DR   PDBsum; 6GR4; -.
DR   PDBsum; 6GR5; -.
DR   PDBsum; 6HHR; -.
DR   PDBsum; 6KSQ; -.
DR   PDBsum; 6LR9; -.
DR   PDBsum; 6LSZ; -.
DR   PDBsum; 6LT8; -.
DR   PDBsum; 6LTI; -.
DR   PDBsum; 6LTK; -.
DR   PDBsum; 6N8X; -.
DR   PDBsum; 6OLX; -.
DR   PDBsum; 6TN4; -.
DR   PDBsum; 6TN5; -.
DR   PDBsum; 6U98; -.
DR   PDBsum; 6U99; -.
DR   PDBsum; 6U9A; -.
DR   PDBsum; 6U9B; -.
DR   PDBsum; 7DMC; -.
DR   PDBsum; 7H9K; -.
DR   PDBsum; 7H9L; -.
DR   PDBsum; 7H9M; -.
DR   PDBsum; 7H9N; -.
DR   PDBsum; 7H9O; -.
DR   PDBsum; 7H9P; -.
DR   PDBsum; 7H9Q; -.
DR   PDBsum; 7H9R; -.
DR   PDBsum; 7H9S; -.
DR   PDBsum; 7H9T; -.
DR   PDBsum; 7H9U; -.
DR   PDBsum; 7H9V; -.
DR   PDBsum; 7H9W; -.
DR   PDBsum; 7H9X; -.
DR   PDBsum; 7H9Y; -.
DR   PDBsum; 7H9Z; -.
DR   PDBsum; 7HA0; -.
DR   PDBsum; 7HA1; -.
DR   PDBsum; 7HA2; -.
DR   PDBsum; 7HA3; -.
DR   PDBsum; 7HA4; -.
DR   PDBsum; 7HA5; -.
DR   PDBsum; 7HA6; -.
DR   PDBsum; 7HA7; -.
DR   PDBsum; 7HA8; -.
DR   PDBsum; 7HA9; -.
DR   PDBsum; 7HAA; -.
DR   PDBsum; 7HAB; -.
DR   PDBsum; 7HAC; -.
DR   PDBsum; 7HAD; -.
DR   PDBsum; 7HAE; -.
DR   PDBsum; 7HAF; -.
DR   PDBsum; 7HAG; -.
DR   PDBsum; 7HAH; -.
DR   PDBsum; 7HAI; -.
DR   PDBsum; 7HAJ; -.
DR   PDBsum; 7HAK; -.
DR   PDBsum; 7HAL; -.
DR   PDBsum; 7HAM; -.
DR   PDBsum; 7HAN; -.
DR   PDBsum; 7HAO; -.
DR   PDBsum; 7HAP; -.
DR   PDBsum; 7HAQ; -.
DR   PDBsum; 7HAR; -.
DR   PDBsum; 7HAS; -.
DR   PDBsum; 7HAT; -.
DR   PDBsum; 7HAU; -.
DR   PDBsum; 7HAV; -.
DR   PDBsum; 7HAW; -.
DR   PDBsum; 7HAX; -.
DR   PDBsum; 7HAY; -.
DR   PDBsum; 7HAZ; -.
DR   PDBsum; 7HB0; -.
DR   PDBsum; 7HB1; -.
DR   PDBsum; 7HB2; -.
DR   PDBsum; 7HB3; -.
DR   PDBsum; 7HB4; -.
DR   PDBsum; 7HB5; -.
DR   PDBsum; 7HB6; -.
DR   PDBsum; 7HB7; -.
DR   PDBsum; 7HB8; -.
DR   PDBsum; 7HB9; -.
DR   PDBsum; 7HBA; -.
DR   PDBsum; 7HBB; -.
DR   PDBsum; 7HBC; -.
DR   PDBsum; 7HBD; -.
DR   PDBsum; 7HBE; -.
DR   PDBsum; 7HBF; -.
DR   PDBsum; 7HBG; -.
DR   PDBsum; 7HBH; -.
DR   PDBsum; 7HBJ; -.
DR   PDBsum; 7HBK; -.
DR   PDBsum; 7HBL; -.
DR   PDBsum; 7HBM; -.
DR   PDBsum; 7HBN; -.
DR   PDBsum; 7HBO; -.
DR   PDBsum; 7HBP; -.
DR   PDBsum; 7HBQ; -.
DR   PDBsum; 7HBR; -.
DR   PDBsum; 7HBS; -.
DR   PDBsum; 7HBT; -.
DR   PDBsum; 7HBU; -.
DR   PDBsum; 7HBV; -.
DR   PDBsum; 7HBW; -.
DR   PDBsum; 7HBX; -.
DR   PDBsum; 7HBY; -.
DR   PDBsum; 7HBZ; -.
DR   PDBsum; 7HC0; -.
DR   PDBsum; 7HC1; -.
DR   PDBsum; 7HC2; -.
DR   PDBsum; 7HC3; -.
DR   PDBsum; 7KRJ; -.
DR   PDBsum; 7KW7; -.
DR   PDBsum; 7L7I; -.
DR   PDBsum; 7L7J; -.
DR   PDBsum; 7LSZ; -.
DR   PDBsum; 7LT0; -.
DR   PDBsum; 7RXZ; -.
DR   PDBsum; 7RY0; -.
DR   PDBsum; 7RY1; -.
DR   PDBsum; 7S8Y; -.
DR   PDBsum; 7S8Z; -.
DR   PDBsum; 7S90; -.
DR   PDBsum; 7S95; -.
DR   PDBsum; 7S98; -.
DR   PDBsum; 7S99; -.
DR   PDBsum; 7S9F; -.
DR   PDBsum; 7S9G; -.
DR   PDBsum; 7S9H; -.
DR   PDBsum; 7S9I; -.
DR   PDBsum; 7UR3; -.
DR   PDBsum; 8AGI; -.
DR   PDBsum; 8AGJ; -.
DR   PDBsum; 8AGL; -.
DR   PDBsum; 8B7I; -.
DR   PDBsum; 8B7J; -.
DR   PDBsum; 8FFV; -.
DR   PDBsum; 8FFW; -.
DR   PDBsum; 8JR6; -.
DR   PDBsum; 8JR7; -.
DR   PDBsum; 8JRA; -.
DR   PDBsum; 8KI4; -.
DR   PDBsum; 8SBT; -.
DR   PDBsum; 8W4V; -.
DR   PDBsum; 8W8K; -.
DR   PDBsum; 8X2R; -.
DR   PDBsum; 9AUU; -.
DR   AlphaFoldDB; P07900; -.
DR   BMRB; P07900; -.
DR   EMDB; EMD-23004; -.
DR   EMDB; EMD-23005; -.
DR   EMDB; EMD-23006; -.
DR   EMDB; EMD-23050; -.
DR   EMDB; EMD-23213; -.
DR   EMDB; EMD-23214; -.
DR   EMDB; EMD-29068; -.
DR   EMDB; EMD-29069; -.
DR   EMDB; EMD-29949; -.
DR   EMDB; EMD-29957; -.
DR   EMDB; EMD-29973; -.
DR   EMDB; EMD-29976; -.
DR   EMDB; EMD-5981; -.
DR   SMR; P07900; -.
DR   BioGRID; 109552; 1359.
DR   ComplexPortal; CPX-3288; HSP90A-CDC37 chaperone complex.
DR   CORUM; P07900; -.
DR   DIP; DIP-27595N; -.
DR   FunCoup; P07900; 2774.
DR   IntAct; P07900; 477.
DR   MINT; P07900; -.
DR   STRING; 9606.ENSP00000335153; -.
DR   BindingDB; P07900; -.
DR   ChEMBL; CHEMBL3880; -.
DR   DrugBank; DB07317; (3E)-3-[(phenylamino)methylidene]dihydrofuran-2(3H)-one.
DR   DrugBank; DB08197; (5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime.
DR   DrugBank; DB08443; 2-(1H-pyrrol-1-ylcarbonyl)benzene-1,3,5-triol.
DR   DrugBank; DB08557; 2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide.
DR   DrugBank; DB08789; 2-AMINO-4-(2,4-DICHLOROPHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE.
DR   DrugBank; DB06969; 2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide.
DR   DrugBank; DB08788; 3,6-DIAMINO-5-CYANO-4-(4-ETHOXYPHENYL)THIENO[2,3-B]PYRIDINE-2-CARBOXAMIDE.
DR   DrugBank; DB07324; 3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ONE.
DR   DrugBank; DB02840; 4-(1,3-Benzodioxol-5-Yl)-5-(5-Ethyl-2,4-Dihydroxyphenyl)-2h-Pyrazole-3-Carboxylic Acid.
DR   DrugBank; DB03749; 4-(1h-Imidazol-4-Yl)-3-(5-Ethyl-2,4-Dihydroxy-Phenyl)-1h-Pyrazole.
DR   DrugBank; DB08787; 4-(2,4-dichlorophenyl)-5-phenyldiazenyl-pyrimidin-2-amine.
DR   DrugBank; DB08786; 4-(2-methoxyethoxy)-6-methylpyrimidin-2-amine.
DR   DrugBank; DB07502; 4-bromo-6-(6-hydroxy-1,2-benzisoxazol-3-yl)benzene-1,3-diol.
DR   DrugBank; DB07100; 4-CHLORO-6-(4-PIPERAZIN-1-YL-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL.
DR   DrugBank; DB06957; 4-CHLORO-6-(4-{4-[4-(METHYLSULFONYL)BENZYL]PIPERAZIN-1-YL}-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL.
DR   DrugBank; DB07601; 4-chloro-6-{5-[(2-morpholin-4-ylethyl)amino]-1,2-benzisoxazol-3-yl}benzene-1,3-diol.
DR   DrugBank; DB08194; 4-methyl-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-amine.
DR   DrugBank; DB08442; 4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol.
DR   DrugBank; DB07495; 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)-1H-PYRAZOLE-3-CARBOXAMIDE.
DR   DrugBank; DB06964; 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)ISOXAZOLE-3-CARBOXAMIDE.
DR   DrugBank; DB06961; 5-(5-chloro-2,4-dihydroxyphenyl)-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]isoxazole-3-carboxamide.
DR   DrugBank; DB06958; 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-PIPERAZIN-1-YL-1H-PYRAZOLE-3-CARBOXAMIDE.
DR   DrugBank; DB07319; 6-(3-BROMO-2-NAPHTHYL)-1,3,5-TRIAZINE-2,4-DIAMINE.
DR   DrugBank; DB03137; 8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9-Pent-9h-Purin-6-Ylamine.
DR   DrugBank; DB03093; 8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine.
DR   DrugBank; DB02550; 8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-2-Fluoro-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine.
DR   DrugBank; DB04505; 8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine.
DR   DrugBank; DB07877; 8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE.
DR   DrugBank; DB04254; 8-Benzo[1,3]Dioxol-,5-Ylmethyl-9-Butyl-2-Fluoro-9h-Purin-6-Ylamine.
DR   DrugBank; DB08436; 8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H.
DR   DrugBank; DB04054; 9-Butyl-8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine.
DR   DrugBank; DB02359; 9-Butyl-8-(2,5-Dimethoxy-Benzyl)-9h-Purin-6-Ylamine.
DR   DrugBank; DB03504; 9-Butyl-8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine.
DR   DrugBank; DB02754; 9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine.
DR   DrugBank; DB03809; 9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine.
DR   DrugBank; DB03899; 9-Butyl-8-(4-Methoxybenzyl)-9h-Purin-6-Amine.
DR   DrugBank; DB12442; Alvespimycin.
DR   DrugBank; DB01025; Amlexanox.
DR   DrugBank; DB12359; BIIB021.
DR   DrugBank; DB07594; CCT-018159.
DR   DrugBank; DB09130; Copper.
DR   DrugBank; DB01003; Cromoglicic acid.
DR   DrugBank; DB02424; Geldanamycin.
DR   DrugBank; DB13023; IPI-493.
DR   DrugBank; DB06956; N-(4-ACETYLPHENYL)-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE.
DR   DrugBank; DB07325; N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE.
DR   DrugBank; DB04588; N-[4-(AMINOSULFONYL)BENZYL]-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE.
DR   DrugBank; DB00716; Nedocromil.
DR   DrugBank; DB06306; Onalespib.
DR   DrugBank; DB09221; Polaprezinc.
DR   DrugBank; DB04216; Quercetin.
DR   DrugBank; DB03758; Radicicol.
DR   DrugBank; DB13174; Rhein.
DR   DrugBank; DB00615; Rifabutin.
DR   DrugBank; DB17055; SNX-2112.
DR   DrugBank; DB06070; SNX-5422.
DR   DrugBank; DB05134; Tanespimycin.
DR   DrugCentral; P07900; -.
DR   GuidetoPHARMACOLOGY; 2905; -.
DR   MoonDB; P07900; Predicted.
DR   CarbonylDB; P07900; -.
DR   GlyConnect; 1301; 1 N-Linked glycan (1 site).
DR   GlyCosmos; P07900; 1 site, 1 glycan.
DR   GlyGen; P07900; 3 sites, 3 N-linked glycans (2 sites), 1 O-linked glycan (1 site).
DR   iPTMnet; P07900; -.
DR   MetOSite; P07900; -.
DR   PhosphoSitePlus; P07900; -.
DR   SwissPalm; P07900; -.
DR   BioMuta; HSP90AA1; -.
DR   DMDM; 92090606; -.
DR   OGP; P07900; -.
DR   REPRODUCTION-2DPAGE; IPI00784295; -.
DR   jPOST; P07900; -.
DR   MassIVE; P07900; -.
DR   PaxDb; 9606-ENSP00000335153; -.
DR   PeptideAtlas; P07900; -.
DR   PRIDE; P07900; -.
DR   ProteomicsDB; 52031; -. [P07900-1]
DR   ProteomicsDB; 52032; -. [P07900-2]
DR   Pumba; P07900; -.
DR   TopDownProteomics; P07900-1; -. [P07900-1]
DR   Antibodypedia; 3676; 1726 antibodies from 45 providers.
DR   DNASU; 3320; -.
DR   Ensembl; ENST00000216281.13; ENSP00000216281.8; ENSG00000080824.20. [P07900-1]
DR   Ensembl; ENST00000334701.11; ENSP00000335153.7; ENSG00000080824.20. [P07900-2]
DR   GeneID; 3320; -.
DR   KEGG; hsa:3320; -.
DR   MANE-Select; ENST00000216281.13; ENSP00000216281.8; NM_005348.4; NP_005339.3.
DR   UCSC; uc001yku.5; human. [P07900-1]
DR   AGR; HGNC:5253; -.
DR   ClinPGx; PA29519; -.
DR   CTD; 3320; -.
DR   DisGeNET; 3320; -.
DR   GeneCards; HSP90AA1; -.
DR   HGNC; HGNC:5253; HSP90AA1.
DR   HPA; ENSG00000080824; Low tissue specificity.
DR   MalaCards; HSP90AA1; -.
DR   MIM; 140571; gene.
DR   OpenTargets; ENSG00000080824; -.
DR   VEuPathDB; HostDB:ENSG00000080824; -.
DR   eggNOG; KOG0019; Eukaryota.
DR   GeneTree; ENSGT01020000230401; -.
DR   HOGENOM; CLU_006684_1_3_1; -.
DR   InParanoid; P07900; -.
DR   OMA; MRRMKEM; -.
DR   OrthoDB; 5426351at2759; -.
DR   PAN-GO; P07900; 13 GO annotations based on evolutionary models.
DR   PhylomeDB; P07900; -.
DR   BRENDA; 3.6.4.10; 2681.
DR   PathwayCommons; P07900; -.
DR   Reactome; R-HSA-1227986; Signaling by ERBB2.
DR   Reactome; R-HSA-1236382; Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants.
DR   Reactome; R-HSA-1474151; Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation.
DR   Reactome; R-HSA-168928; DDX58/IFIH1-mediated induction of interferon-alpha/beta.
DR   Reactome; R-HSA-192905; vRNP Assembly.
DR   Reactome; R-HSA-2029482; Regulation of actin dynamics for phagocytic cup formation.
DR   Reactome; R-HSA-203615; eNOS activation.
DR   Reactome; R-HSA-2565942; Regulation of PLK1 Activity at G2/M Transition.
DR   Reactome; R-HSA-3000484; Scavenging by Class F Receptors.
DR   Reactome; R-HSA-3371497; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand.
DR   Reactome; R-HSA-3371511; HSF1 activation.
DR   Reactome; R-HSA-3371568; Attenuation phase.
DR   Reactome; R-HSA-3371571; HSF1-dependent transactivation.
DR   Reactome; R-HSA-380259; Loss of Nlp from mitotic centrosomes.
DR   Reactome; R-HSA-380270; Recruitment of mitotic centrosome proteins and complexes.
DR   Reactome; R-HSA-380284; Loss of proteins required for interphase microtubule organization from the centrosome.
DR   Reactome; R-HSA-380320; Recruitment of NuMA to mitotic centrosomes.
DR   Reactome; R-HSA-399954; Sema3A PAK dependent Axon repulsion.
DR   Reactome; R-HSA-4420097; VEGFA-VEGFR2 Pathway.
DR   Reactome; R-HSA-5218920; VEGFR2 mediated vascular permeability.
DR   Reactome; R-HSA-5336415; Uptake and function of diphtheria toxin.
DR   Reactome; R-HSA-5601884; PIWI-interacting RNA (piRNA) biogenesis.
DR   Reactome; R-HSA-5620912; Anchoring of the basal body to the plasma membrane.
DR   Reactome; R-HSA-5637810; Constitutive Signaling by EGFRvIII.
DR   Reactome; R-HSA-5675482; Regulation of necroptotic cell death.
DR   Reactome; R-HSA-6785807; Interleukin-4 and Interleukin-13 signaling.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-8852276; The role of GTSE1 in G2/M progression after G2 checkpoint.
DR   Reactome; R-HSA-8854518; AURKA Activation by TPX2.
DR   Reactome; R-HSA-8863795; Downregulation of ERBB2 signaling.
DR   Reactome; R-HSA-8939211; ESR-mediated signaling.
DR   Reactome; R-HSA-9009391; Extra-nuclear estrogen signaling.
DR   Reactome; R-HSA-9013418; RHOBTB2 GTPase cycle.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   Reactome; R-HSA-9613829; Chaperone Mediated Autophagy.
DR   Reactome; R-HSA-9634285; Constitutive Signaling by Overexpressed ERBB2.
DR   Reactome; R-HSA-9646399; Aggrephagy.
DR   Reactome; R-HSA-9652282; Drug-mediated inhibition of ERBB2 signaling.
DR   Reactome; R-HSA-9664565; Signaling by ERBB2 KD Mutants.
DR   Reactome; R-HSA-9665233; Resistance of ERBB2 KD mutants to trastuzumab.
DR   Reactome; R-HSA-9665244; Resistance of ERBB2 KD mutants to sapitinib.
DR   Reactome; R-HSA-9665245; Resistance of ERBB2 KD mutants to tesevatinib.
DR   Reactome; R-HSA-9665246; Resistance of ERBB2 KD mutants to neratinib.
DR   Reactome; R-HSA-9665247; Resistance of ERBB2 KD mutants to osimertinib.
DR   Reactome; R-HSA-9665249; Resistance of ERBB2 KD mutants to afatinib.
DR   Reactome; R-HSA-9665250; Resistance of ERBB2 KD mutants to AEE788.
DR   Reactome; R-HSA-9665251; Resistance of ERBB2 KD mutants to lapatinib.
DR   Reactome; R-HSA-9665348; Signaling by ERBB2 ECD mutants.
DR   Reactome; R-HSA-9665686; Signaling by ERBB2 TMD/JMD mutants.
DR   Reactome; R-HSA-9665737; Drug resistance in ERBB2 TMD/JMD mutants.
DR   Reactome; R-HSA-9679191; Potential therapeutics for SARS.
DR   Reactome; R-HSA-9705671; SARS-CoV-2 activates/modulates innate and adaptive immune responses.
DR   Reactome; R-HSA-9820962; Assembly and release of respiratory syncytial virus (RSV) virions.
DR   Reactome; R-HSA-9834752; Respiratory syncytial virus genome replication.
DR   SignaLink; P07900; -.
DR   SIGNOR; P07900; -.
DR   Agora; ENSG00000080824; -.
DR   BioGRID-ORCS; 3320; 39 hits in 1173 CRISPR screens.
DR   CD-CODE; 8C2F96ED; Centrosome.
DR   CD-CODE; 91857CE7; Nucleolus.
DR   CD-CODE; DEE660B4; Stress granule.
DR   CD-CODE; FB4E32DD; Presynaptic clusters and postsynaptic densities.
DR   ChiTaRS; HSP90AA1; human.
DR   EvolutionaryTrace; P07900; -.
DR   GenomeRNAi; 3320; -.
DR   Pharos; P07900; Tchem.
DR   PRO; PR:P07900; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   RNAct; P07900; protein.
DR   Bgee; ENSG00000080824; Expressed in Brodmann (1909) area 23 and 218 other cell types or tissues.
DR   ExpressionAtlas; P07900; baseline and differential.
DR   GO; GO:0044295; C:axonal growth cone; ISS:ARUK-UCL.
DR   GO; GO:0016323; C:basolateral plasma membrane; IEA:Ensembl.
DR   GO; GO:0031526; C:brush border membrane; IEA:Ensembl.
DR   GO; GO:0009986; C:cell surface; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IDA:CAFA.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0044294; C:dendritic growth cone; ISS:ARUK-UCL.
DR   GO; GO:0071682; C:endocytic vesicle lumen; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0031012; C:extracellular matrix; IEA:Ensembl.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:1904813; C:ficolin-1-rich granule lumen; TAS:Reactome.
DR   GO; GO:0043202; C:lysosomal lumen; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0043209; C:myelin sheath; IBA:GO_Central.
DR   GO; GO:0043025; C:neuronal cell body; ISS:ARUK-UCL.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISS:ARUK-UCL.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0101031; C:protein folding chaperone complex; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB.
DR   GO; GO:0034774; C:secretory granule lumen; TAS:Reactome.
DR   GO; GO:0097226; C:sperm mitochondrial sheath; IEA:Ensembl.
DR   GO; GO:0097524; C:sperm plasma membrane; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IDA:UniProtKB.
DR   GO; GO:0140662; F:ATP-dependent protein folding chaperone; IEA:InterPro.
DR   GO; GO:0002135; F:CTP binding; IEA:Ensembl.
DR   GO; GO:0032564; F:dATP binding; IEA:Ensembl.
DR   GO; GO:0097718; F:disordered domain specific binding; IPI:CAFA.
DR   GO; GO:0070182; F:DNA polymerase binding; IPI:BHF-UCL.
DR   GO; GO:0140767; F:enzyme-substrate adaptor activity; EXP:Reactome.
DR   GO; GO:0005525; F:GTP binding; IEA:Ensembl.
DR   GO; GO:0051020; F:GTPase binding; IPI:UniProtKB.
DR   GO; GO:0042826; F:histone deacetylase binding; IPI:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; IDA:UniProtKB.
DR   GO; GO:0023026; F:MHC class II protein complex binding; HDA:UniProtKB.
DR   GO; GO:0003729; F:mRNA binding; IEA:Ensembl.
DR   GO; GO:0030235; F:nitric-oxide synthase regulator activity; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0019903; F:protein phosphatase binding; IEA:Ensembl.
DR   GO; GO:1990782; F:protein tyrosine kinase binding; IPI:UniProtKB.
DR   GO; GO:0051022; F:Rho GDP-dissociation inhibitor binding; IEA:Ensembl.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0097110; F:scaffold protein binding; IPI:UniProtKB.
DR   GO; GO:0017098; F:sulfonylurea receptor binding; IEA:Ensembl.
DR   GO; GO:0048156; F:tau protein binding; IPI:ARUK-UCL.
DR   GO; GO:0030911; F:TPR domain binding; IDA:UniProtKB.
DR   GO; GO:0044325; F:transmembrane transporter binding; IEA:Ensembl.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:ARUK-UCL.
DR   GO; GO:0051082; F:unfolded protein binding; IBA:GO_Central.
DR   GO; GO:0002134; F:UTP binding; IEA:Ensembl.
DR   GO; GO:0002218; P:activation of innate immune response; IDA:UniProtKB.
DR   GO; GO:0010659; P:cardiac muscle cell apoptotic process; IEA:Ensembl.
DR   GO; GO:0034605; P:cellular response to heat; IBA:GO_Central.
DR   GO; GO:0098586; P:cellular response to virus; IDA:UniProtKB.
DR   GO; GO:0061684; P:chaperone-mediated autophagy; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0051131; P:chaperone-mediated protein complex assembly; IDA:BHF-UCL.
DR   GO; GO:0006839; P:mitochondrial transport; TAS:UniProtKB.
DR   GO; GO:1902988; P:neurofibrillary tangle assembly; IDA:ARUK-UCL.
DR   GO; GO:0001764; P:neuron migration; IEA:Ensembl.
DR   GO; GO:0046209; P:nitric oxide metabolic process; TAS:Reactome.
DR   GO; GO:0060452; P:positive regulation of cardiac muscle contraction; IEA:Ensembl.
DR   GO; GO:0045793; P:positive regulation of cell size; IEA:Ensembl.
DR   GO; GO:0002230; P:positive regulation of defense response to virus by host; IDA:UniProtKB.
DR   GO; GO:0032728; P:positive regulation of interferon-beta production; IDA:UniProtKB.
DR   GO; GO:0010592; P:positive regulation of lamellipodium assembly; IEA:Ensembl.
DR   GO; GO:0045429; P:positive regulation of nitric oxide biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0045732; P:positive regulation of protein catabolic process; IGI:ARUK-UCL.
DR   GO; GO:0042307; P:positive regulation of protein import into nucleus; IEA:Ensembl.
DR   GO; GO:0032273; P:positive regulation of protein polymerization; IDA:ARUK-UCL.
DR   GO; GO:0032212; P:positive regulation of telomere maintenance via telomerase; TAS:BHF-UCL.
DR   GO; GO:0006457; P:protein folding; IBA:GO_Central.
DR   GO; GO:0030150; P:protein import into mitochondrial matrix; IDA:BHF-UCL.
DR   GO; GO:0042026; P:protein refolding; TAS:UniProtKB.
DR   GO; GO:0050821; P:protein stabilization; IMP:UniProtKB.
DR   GO; GO:0043335; P:protein unfolding; NAS:ParkinsonsUK-UCL.
DR   GO; GO:0042981; P:regulation of apoptotic process; IDA:UniProtKB.
DR   GO; GO:0099072; P:regulation of postsynaptic membrane neurotransmitter receptor levels; IEA:Ensembl.
DR   GO; GO:0032880; P:regulation of protein localization; ISS:ARUK-UCL.
DR   GO; GO:0031396; P:regulation of protein ubiquitination; IDA:BHF-UCL.
DR   GO; GO:0043254; P:regulation of protein-containing complex assembly; NAS:ParkinsonsUK-UCL.
DR   GO; GO:0046677; P:response to antibiotic; ISS:AgBase.
DR   GO; GO:0042220; P:response to cocaine; IEA:Ensembl.
DR   GO; GO:0009409; P:response to cold; ISS:AgBase.
DR   GO; GO:0043627; P:response to estrogen; IEA:Ensembl.
DR   GO; GO:0009408; P:response to heat; ISS:AgBase.
DR   GO; GO:0009651; P:response to salt stress; IEA:Ensembl.
DR   GO; GO:0006986; P:response to unfolded protein; NAS:UniProtKB.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEA:Ensembl.
DR   GO; GO:0003009; P:skeletal muscle contraction; IEA:Ensembl.
DR   GO; GO:1905323; P:telomerase holoenzyme complex assembly; IDA:BHF-UCL.
DR   GO; GO:0007004; P:telomere maintenance via telomerase; IDA:BHF-UCL.
DR   CDD; cd16927; HATPase_Hsp90-like; 1.
DR   FunFam; 1.20.120.790:FF:000001; Heat shock protein 90 alpha; 1.
DR   FunFam; 3.30.230.80:FF:000001; Heat shock protein 90 alpha; 1.
DR   FunFam; 3.40.50.11260:FF:000001; Heat shock protein 90 alpha; 1.
DR   FunFam; 3.30.565.10:FF:000204; Heat shock protein HSP 90-beta; 1.
DR   Gene3D; 3.30.230.80; -; 1.
DR   Gene3D; 3.40.50.11260; -; 1.
DR   Gene3D; 1.20.120.790; Heat shock protein 90, C-terminal domain; 1.
DR   Gene3D; 3.30.565.10; Histidine kinase-like ATPase, C-terminal domain; 1.
DR   HAMAP; MF_00505; HSP90; 1.
DR   InterPro; IPR036890; HATPase_C_sf.
DR   InterPro; IPR003594; HATPase_dom.
DR   InterPro; IPR019805; Heat_shock_protein_90_CS.
DR   InterPro; IPR037196; HSP90_C.
DR   InterPro; IPR001404; Hsp90_fam.
DR   InterPro; IPR020575; Hsp90_N.
DR   InterPro; IPR020568; Ribosomal_Su5_D2-typ_SF.
DR   NCBIfam; NF003555; PRK05218.1; 1.
DR   PANTHER; PTHR11528; HEAT SHOCK PROTEIN 90 FAMILY MEMBER; 1.
DR   Pfam; PF13589; HATPase_c_3; 1.
DR   Pfam; PF00183; HSP90; 1.
DR   PIRSF; PIRSF002583; Hsp90; 1.
DR   PRINTS; PR00775; HEATSHOCK90.
DR   SMART; SM00387; HATPase_c; 1.
DR   SUPFAM; SSF55874; ATPase domain of HSP90 chaperone/DNA topoisomerase II/histidine kinase; 1.
DR   SUPFAM; SSF110942; HSP90 C-terminal domain; 1.
DR   SUPFAM; SSF54211; Ribosomal protein S5 domain 2-like; 1.
DR   PROSITE; PS00298; HSP90; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Cell membrane; Chaperone; Cytoplasm; Direct protein sequencing;
KW   Host-virus interaction; Hydrolase; Membrane; Mitochondrion;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Proteomics identification;
KW   Reference proteome; S-nitrosylation; Stress response; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:2492519"
FT   CHAIN           2..732
FT                   /note="Heat shock protein HSP 90-alpha"
FT                   /id="PRO_0000062911"
FT   REGION          9..236
FT                   /note="Interaction with NR3C1"
FT                   /evidence="ECO:0000250|UniProtKB:P07901"
FT   REGION          225..278
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          271..616
FT                   /note="Interaction with NR3C1"
FT                   /evidence="ECO:0000250|UniProtKB:P07901"
FT   REGION          284..732
FT                   /note="Interaction with FLCN and FNIP1"
FT                   /evidence="ECO:0000269|PubMed:27353360"
FT   REGION          284..620
FT                   /note="Interaction with FNIP2 and TSC1"
FT                   /evidence="ECO:0000269|PubMed:27353360,
FT                   ECO:0000269|PubMed:29127155"
FT   REGION          628..731
FT                   /note="Interaction with NR1D1"
FT                   /evidence="ECO:0000250|UniProtKB:P07901"
FT   REGION          682..732
FT                   /note="Required for homodimerization"
FT                   /evidence="ECO:0000269|PubMed:8289821"
FT   REGION          700..732
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          728..732
FT                   /note="Essential for interaction with SMYD3, TSC1 and
FT                   STIP1/HOP"
FT                   /evidence="ECO:0000269|PubMed:25738358,
FT                   ECO:0000269|PubMed:29127155"
FT   REGION          729..732
FT                   /note="Essential for interaction with SGTA and TTC1"
FT                   /evidence="ECO:0000269|PubMed:15708368"
FT   MOTIF           723..732
FT                   /note="TPR repeat-binding"
FT                   /evidence="ECO:0000269|PubMed:16307917"
FT   COMPBIAS        230..246
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        256..268
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         51
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT   BINDING         93
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT   BINDING         112
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250"
FT   BINDING         138
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT   BINDING         400
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         5
FT                   /note="Phosphothreonine; by PRKDC"
FT                   /evidence="ECO:0000269|PubMed:2507541"
FT   MOD_RES         7
FT                   /note="Phosphothreonine; by PRKDC"
FT                   /evidence="ECO:0000269|PubMed:2507541"
FT   MOD_RES         58
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P07901"
FT   MOD_RES         84
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P07901"
FT   MOD_RES         231
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:2492519,
FT                   ECO:0007744|PubMed:17081983, ECO:0007744|PubMed:18318008,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         252
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18088087,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163"
FT   MOD_RES         263
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:2492519,
FT                   ECO:0007744|PubMed:16807684, ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:18088087, ECO:0007744|PubMed:18318008,
FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:18691976,
FT                   ECO:0007744|PubMed:19367720, ECO:0007744|PubMed:23186163"
FT   MOD_RES         313
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P07901"
FT   MOD_RES         443
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         453
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P82995"
FT   MOD_RES         458
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         476
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         489
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         492
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P07901"
FT   MOD_RES         585
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         598
FT                   /note="S-nitrosocysteine"
FT                   /evidence="ECO:0000269|PubMed:15937123"
FT   MOD_RES         641
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         1
FT                   /note="M -> MPPCSGGDGSTPPGPSLRDRDCPAQSAEYPRDRLDPRPGSPSEASSP
FT                   PFLRSRAPVNWYQEKAQVFLWHLMVSGSTTLLCLWKQPFHVSAFPVTASLAFRQSQGAG
FT                   QHLYKDLQPFILLRLLM (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:16269234"
FT                   /id="VSP_026604"
FT   MUTAGEN         47
FT                   /note="E->A: Strong ATP-binding. Strong interaction with
FT                   HSF1, HIF1A, ERBB2, MET, KEAP1 and RHOBTB2. No effect on
FT                   interaction with TSC1."
FT                   /evidence="ECO:0000269|PubMed:26517842,
FT                   ECO:0000269|PubMed:29127155"
FT   MUTAGEN         93
FT                   /note="D->A: Impaired ATP-binding. Strong interaction with
FT                   HIF1A, MET, KEAP1 and RHOBTB2. Loss of interaction with
FT                   HSF1 and ERBB2. Los of interaction with TSC1."
FT                   /evidence="ECO:0000269|PubMed:26517842,
FT                   ECO:0000269|PubMed:29127155"
FT   MUTAGEN         97
FT                   /note="G->D: Abolishes ATPase activity."
FT                   /evidence="ECO:0000269|PubMed:18256191"
FT   MUTAGEN         313
FT                   /note="Y->E: Loss of interaction with TSC1 and increases
FT                   interaction with AHSA1."
FT                   /evidence="ECO:0000269|PubMed:29127155"
FT   MUTAGEN         313
FT                   /note="Y->F: No deffect on the interaction with TSC1."
FT                   /evidence="ECO:0000269|PubMed:29127155"
FT   MUTAGEN         598
FT                   /note="C->A,N,D: Reduces ATPase activity and client protein
FT                   activation."
FT                   /evidence="ECO:0000269|PubMed:15937123,
FT                   ECO:0000269|PubMed:19696785"
FT   MUTAGEN         598
FT                   /note="C->S: Loss of S-nitrosylation."
FT                   /evidence="ECO:0000269|PubMed:15937123,
FT                   ECO:0000269|PubMed:19696785"
FT   MUTAGEN         728..732
FT                   /note="MEEVD->AAAA: Loss of interaction with TOMM70. No
FT                   effect on interaction with IRF3."
FT                   /evidence="ECO:0000269|PubMed:25609812"
FT   MUTAGEN         728..732
FT                   /note="Missing: Loss of interaction with TSC1."
FT                   /evidence="ECO:0000269|PubMed:29127155"
FT   MUTAGEN         729..732
FT                   /note="Missing: Loss of interaction with TOMM70."
FT                   /evidence="ECO:0000269|PubMed:20628368"
FT   MUTAGEN         731..732
FT                   /note="VD->AA: Loss of interaction with TOMM70. No effect
FT                   on interaction with IRF3."
FT                   /evidence="ECO:0000269|PubMed:20628368,
FT                   ECO:0000269|PubMed:25609812"
FT   CONFLICT        63
FT                   /note="S -> T (in Ref. 1; CAA33259)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        74
FT                   /note="K -> R (in Ref. 4; CAI64495 and 6; BAG51711)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        86
FT                   /note="D -> G (in Ref. 4; CAI64495 and 6; BAG51711)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        162
FT                   /note="W -> D (in Ref. 15; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   HELIX           2..5
FT                   /evidence="ECO:0007829|PDB:6GQS"
FT   STRAND          18..21
FT                   /evidence="ECO:0007829|PDB:5J80"
FT   HELIX           24..35
FT                   /evidence="ECO:0007829|PDB:5J80"
FT   TURN            39..42
FT                   /evidence="ECO:0007829|PDB:6GPF"
FT   HELIX           43..65
FT                   /evidence="ECO:0007829|PDB:5J80"
FT   HELIX           67..70
FT                   /evidence="ECO:0007829|PDB:5J80"
FT   STRAND          78..83
FT                   /evidence="ECO:0007829|PDB:5J80"
FT   TURN            84..87
FT                   /evidence="ECO:0007829|PDB:5J80"
FT   STRAND          88..93
FT                   /evidence="ECO:0007829|PDB:5J80"
FT   HELIX           100..104
FT                   /evidence="ECO:0007829|PDB:5J80"
FT   TURN            105..108
FT                   /evidence="ECO:0007829|PDB:5J80"
FT   HELIX           111..123
FT                   /evidence="ECO:0007829|PDB:5J80"
FT   HELIX           128..134
FT                   /evidence="ECO:0007829|PDB:5J80"
FT   HELIX           137..143
FT                   /evidence="ECO:0007829|PDB:5J80"
FT   STRAND          145..153
FT                   /evidence="ECO:0007829|PDB:5J80"
FT   STRAND          155..157
FT                   /evidence="ECO:0007829|PDB:2WI6"
FT   STRAND          160..164
FT                   /evidence="ECO:0007829|PDB:5J80"
FT   STRAND          166..168
FT                   /evidence="ECO:0007829|PDB:8FFV"
FT   STRAND          169..174
FT                   /evidence="ECO:0007829|PDB:5J80"
FT   STRAND          181..190
FT                   /evidence="ECO:0007829|PDB:5J80"
FT   HELIX           192..198
FT                   /evidence="ECO:0007829|PDB:5J80"
FT   HELIX           200..210
FT                   /evidence="ECO:0007829|PDB:5J80"
FT   STRAND          212..216
FT                   /evidence="ECO:0007829|PDB:3VHC"
FT   STRAND          218..220
FT                   /evidence="ECO:0007829|PDB:5J80"
FT   TURN            221..224
FT                   /evidence="ECO:0007829|PDB:3T1K"
FT   STRAND          225..227
FT                   /evidence="ECO:0007829|PDB:3T1K"
FT   HELIX           228..230
FT                   /evidence="ECO:0007829|PDB:2XJX"
FT   STRAND          284..289
FT                   /evidence="ECO:0007829|PDB:7KRJ"
FT   HELIX           296..298
FT                   /evidence="ECO:0007829|PDB:7RY0"
FT   HELIX           301..303
FT                   /evidence="ECO:0007829|PDB:6KSQ"
FT   HELIX           306..316
FT                   /evidence="ECO:0007829|PDB:7RY0"
FT   STRAND          324..331
FT                   /evidence="ECO:0007829|PDB:7RY0"
FT   STRAND          333..335
FT                   /evidence="ECO:0007829|PDB:7RY0"
FT   STRAND          337..343
FT                   /evidence="ECO:0007829|PDB:7RY0"
FT   TURN            351..353
FT                   /evidence="ECO:0007829|PDB:6KSQ"
FT   STRAND          361..365
FT                   /evidence="ECO:0007829|PDB:7RY0"
FT   STRAND          368..372
FT                   /evidence="ECO:0007829|PDB:7RY0"
FT   HELIX           375..377
FT                   /evidence="ECO:0007829|PDB:7RY0"
FT   HELIX           380..382
FT                   /evidence="ECO:0007829|PDB:7RY0"
FT   STRAND          386..394
FT                   /evidence="ECO:0007829|PDB:7RY0"
FT   TURN            400..405
FT                   /evidence="ECO:0007829|PDB:7RY0"
FT   HELIX           407..428
FT                   /evidence="ECO:0007829|PDB:7RY0"
FT   HELIX           431..451
FT                   /evidence="ECO:0007829|PDB:7RY0"
FT   HELIX           453..455
FT                   /evidence="ECO:0007829|PDB:6KSQ"
FT   HELIX           456..460
FT                   /evidence="ECO:0007829|PDB:7RY0"
FT   STRAND          465..467
FT                   /evidence="ECO:0007829|PDB:7RY0"
FT   TURN            468..472
FT                   /evidence="ECO:0007829|PDB:7RY0"
FT   HELIX           477..482
FT                   /evidence="ECO:0007829|PDB:7RY0"
FT   STRAND          490..495
FT                   /evidence="ECO:0007829|PDB:7RY0"
FT   HELIX           499..503
FT                   /evidence="ECO:0007829|PDB:7RY0"
FT   HELIX           506..508
FT                   /evidence="ECO:0007829|PDB:7RY0"
FT   HELIX           509..513
FT                   /evidence="ECO:0007829|PDB:7RY0"
FT   STRAND          518..521
FT                   /evidence="ECO:0007829|PDB:7RY0"
FT   HELIX           524..529
FT                   /evidence="ECO:0007829|PDB:7RY0"
FT   TURN            530..532
FT                   /evidence="ECO:0007829|PDB:7RY0"
FT   STRAND          539..543
FT                   /evidence="ECO:0007829|PDB:7RY0"
FT   STRAND          546..548
FT                   /evidence="ECO:0007829|PDB:7RY0"
FT   HELIX           555..579
FT                   /evidence="ECO:0007829|PDB:7RY0"
FT   HELIX           580..582
FT                   /evidence="ECO:0007829|PDB:3Q6M"
FT   STRAND          584..588
FT                   /evidence="ECO:0007829|PDB:7RY0"
FT   STRAND          593..601
FT                   /evidence="ECO:0007829|PDB:7RY0"
FT   STRAND          603..605
FT                   /evidence="ECO:0007829|PDB:7KRJ"
FT   HELIX           608..613
FT                   /evidence="ECO:0007829|PDB:7RY0"
FT   HELIX           622..624
FT                   /evidence="ECO:0007829|PDB:7KRJ"
FT   TURN            625..629
FT                   /evidence="ECO:0007829|PDB:7KRJ"
FT   STRAND          632..636
FT                   /evidence="ECO:0007829|PDB:7RY0"
FT   HELIX           641..652
FT                   /evidence="ECO:0007829|PDB:7RY0"
FT   HELIX           657..673
FT                   /evidence="ECO:0007829|PDB:7RY0"
FT   HELIX           681..696
FT                   /evidence="ECO:0007829|PDB:7RY0"
FT   STRAND          728..730
FT                   /evidence="ECO:0007829|PDB:4CGW"
FT   VARIANT         P07900-2:71
FT                   /note="M -> L (in dbSNP:rs8005905)"
FT                   /evidence="ECO:0000305"
FT                   /id="VAR_082835"
SQ   SEQUENCE   732 AA;  84660 MW;  969F65FCC0BC86FD CRC64;
     MPEETQTQDQ PMEEEEVETF AFQAEIAQLM SLIINTFYSN KEIFLRELIS NSSDALDKIR
     YESLTDPSKL DSGKELHINL IPNKQDRTLT IVDTGIGMTK ADLINNLGTI AKSGTKAFME
     ALQAGADISM IGQFGVGFYS AYLVAEKVTV ITKHNDDEQY AWESSAGGSF TVRTDTGEPM
     GRGTKVILHL KEDQTEYLEE RRIKEIVKKH SQFIGYPITL FVEKERDKEV SDDEAEEKED
     KEEEKEKEEK ESEDKPEIED VGSDEEEEKK DGDKKKKKKI KEKYIDQEEL NKTKPIWTRN
     PDDITNEEYG EFYKSLTNDW EDHLAVKHFS VEGQLEFRAL LFVPRRAPFD LFENRKKKNN
     IKLYVRRVFI MDNCEELIPE YLNFIRGVVD SEDLPLNISR EMLQQSKILK VIRKNLVKKC
     LELFTELAED KENYKKFYEQ FSKNIKLGIH EDSQNRKKLS ELLRYYTSAS GDEMVSLKDY
     CTRMKENQKH IYYITGETKD QVANSAFVER LRKHGLEVIY MIEPIDEYCV QQLKEFEGKT
     LVSVTKEGLE LPEDEEEKKK QEEKKTKFEN LCKIMKDILE KKVEKVVVSN RLVTSPCCIV
     TSTYGWTANM ERIMKAQALR DNSTMGYMAA KKHLEINPDH SIIETLRQKA EADKNDKSVK
     DLVILLYETA LLSSGFSLED PQTHANRIYR MIKLGLGIDE DDPTADDTSA AVTEEMPPLE
     GDDDTSRMEE VD
//
